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Short Summary 
 
The porcine ear skin model has become a well-accepted in vitro model for follicular uptake studies of 
nanoparticle-based drug delivery systems. The present study further confirms the suitability and 
transferability of this model to human tissue regarding chemical composition of various hair follicle 
(HF) components, as well as expression and localization of follicular tight junction (TJ) proteins 
claudin-1, -3, -4, occludin, and ZO-1, by means of confocal Raman microscopy, qPCR, and 
immunostaining, respectively. Moreover, combining confocal Raman microscopy and optical 
profilometry allowed for a 3-D analysis of cyanoacrylate biopsies, the main analytical method to 
quantify follicular uptake, showing the removal of intact HFs and thus only further corroborating 
suitability and reliability of this technique. Furthermore, functionality of follicular TJs was 
investigated and a continuous TJ barrier was detected throughout the HF via an extracellular tracer 
molecule, confirming a second line of defense for xenobiotics. Modification of this barrier using 
EDTA was feasible. Lastly, the interplay of follicular uptake and interfollicular, transdermal 
permeation of three different nanocarriers for Clobetasol was evaluated. Although differing in the 
molecular architecture, all three particles displayed similar drug-releases and a similar reduction in 
skin permeation as opposed to dissolved drug. Follicular uptake, however, was particle-dependent. 
Massage amplified this uptake. 
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Kurzzusammenfassung 
 
Das Schweineohr-Hautmodell ist ein anerkanntes in vitro-Modell für follikuläre Aufnahmestudien von 
Nanopartikel-basierten Wirkstoffträgersystemen. Die vorliegende Arbeit bestätigt die Übertragbarkeit 
dieses Modells auf den Menschen hinsichtlich chemischer Zusammensetzung der verschiedenen 
Haarfollikel (HF)-Komponenten, sowie der Expression und Lokalisierung der follikulären Tight 
Junction (TJ) Proteine Claudin-1, -3, -4, Occludin und ZO-1, welche mittels konfokaler Raman 
Mikroskopie, qPCR und Immunfärbung gezeigt werden konnten. Durch die Kombination von 
konfokaler Raman-Mikroskopie und optischer Profilometrie wurde zudem eine 3D-Analyse von 
Cyanoacrylatbiopsien durchgeführt. Diese Analyse zeigte eine Entfernung des gesamten, intakten HF, 
wodurch Nutzen und Zuverlässigkeit der Technik bewiesen wurden. Ebenfalls wurde die 
Funktionalität der follikulären TJs untersucht. Mit Hilfe eines extrazellulären Tracermoleküls wurde 
eine intakte, kontinuierliche TJ-Barriere über den gesamten HF festgestellt, welche durch EDTA 
geöffnet werden konnte. Schließlich wurde ein Zusammenspiel zwischen follikulärer Aufnahme und 
Hautpermeation durch Verwendung dreier verschiedener mit Clobetasol-beladener Nanopartikel 
gezeigt. Obwohl sich diese in ihrem molekularen Aufbau unterscheiden, erzeugten alle ähnliche 
Arzneimittel-Freisetzungsprofile, sowie eine vergleichbare Minderung der Hautpermeation. Die 
follikuläre Aufnahme war jedoch Partikelabhängig. Massage verstärkte diese Aufnahme stets. 
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1. General Introduction 
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1.1. The Skin 
The skin is the largest visible organ of the mammalian body (in humans about 2 m
2
) and, due to its 
easy accessibility, a very attractive site for drug administration. It represents the interface between the 
body and the external environment. Due to its complex structure it is indispensable in its function as a 
barrier, regulating heat and water loss from the inside, as well as invasion of exogenous substances 
from the outside. Furthermore, the skin is important for xenobiotic metabolism and sensation [1].  
It can be roughly divided into three sections: the epidermis, the dermis, and the subcutis. Detailed 
information about anatomy, organization, and function of human skin can be found in references [2, 
3]. 
1.1.1. The Epidermis 
The epidermis is the heterogeneous, outermost layer of the skin and due to its composition it is mainly 
in charge of barrier function. It can again be subdivided into the hydrophobic stratum corneum (SC) 
and the rather hydrophilic viable epidermis (the stratum granulosum, the stratum spinosum, and the 
stratum basale, a.k.a. stratum germinativum).
1
  
The stratum corneum, the outermost layer of the epidermis, is also known as the rate-limiting barrier 
in skin permeability. It is composed of large, keratin-based, non-viable, cornified plate-like cells 
(corneocytes), which are embedded in intercellular lipids [4]. Due to this organization and its graphic 
resemblance, it can often be found in literature described as the brick-and-mortar model (see Figure 1), 
even though the in vivo structure is more complicated [5].  
Like other renewable tissue, the epidermis maintains its structural stability through a continuous 
process of cell renewal (starting at the basal cell layer) balanced by desquamation (shedding of the 
terminally differentiated corneocytes of the SC), exhibiting a turnover time of ~28 days [6]. During 
this time the cells (keratinocytes) undergo a differentiation process in which expression of many 
epidermal differentiation markers is initiated; as differentiation proceeds they move from the stratum 
basale towards the SC, where they eventually become corneocytes. Besides providing nutrients for 
this differentiation process, the viable epidermis also provides protection against exposure to 
                                                     
1
 Another layer, the stratum lucidum, is only present in some anatomical areas like the sole of the feet or the 
palm of the hand, e.g. areas of “thick skin”. It is a thin, clear layer of dead skin cells present between the stratum 
corneum and stratum granulosum. 
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ultraviolet light via melanin production by melanocytes, and is involved in the immune response 
(antigen presenting cells mainly present in stratum spinosum) [6].  
 
Figure 1: Diagram of the stratum corneum structure also known as the brick-and-mortar model (modified from [2]; not 
drawn to scale). 
Another cell type present in the basal layer of the epidermis and epithelial sheath of the hair follicle is 
the Merkel cell [7]. These sensory cells are in charge of transmitting signals via synaptic contacts to 
somatosensory neurons thereby allowing the sensation of touch.  
1.1.2. The Dermis 
The dermis is mainly composed of collagen and elastic fibers, giving rise to the skins’ pliability, 
elasticity, and tensile strength [8]. These fibers plus cells like fibroblasts (mainly responsible for the 
synthesis of collagen and elastin), macrophages, or mast cells, are embedded in a matrix made up of 
proteoglycans and gelatin. Additionally, the dermis contains vascular channels (providing nourishment 
and waste removal for dermal and epidermal cells), lymph vessels and nerves, as well as skin 
appendages like the hair follicle or secretory glands [2]. 
1.1.3. The Subcutis  
The subcutis, or hypodermis, is located beneath the dermis and is mainly responsible for insulating the 
body, providing an energy reservoir, and for acting as a shock absorber or cushion for the body. It is 
mainly composed of loose fat, connective tissue, blood vessels, and nerves. 
1.2. The Hair Follicle 
Anatomically, the hair follicle (HF) embodies a tubular invagination of the epidermis. At birth, each 
person is covered with around 5 million HFs [9]. This number does not increase with time, although 
the size of the follicles, as well as the hairs, can be subject to change throughout a person’s life.  
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Already during embryogenesis, the formation of the HF occurs and is dependent upon a series of 
signals that are sent between dermal cells and underlying epithelial cells [10]. These signals are 
responsible for triggering fate changes in both cell populations, which in turn results in the 
differentiation of the hair shaft, the root sheaths, and the dermal papillae. Once the HF is established, 
hair growth is a cyclic process with every HF undergoing an active growing phase (anagen), a 
regression and shortening phase (catagen), and a resting phase (telogen). Based on this, the mature HF 
can be divided into an “upper part”, which does not cycle visibly, and a “lower part”, which undergoes 
continuous remodeling during each hair cycle [11]. 
1.2.1.  Anatomy of the Hair Follicle 
The HF itself can be considered a complex miniorgan of the skin, which includes the pilosebacious 
unit, the apocrine gland and the arrector pili muscle [11]. For the purpose of this work, however, the 
term HF only refers to the structure made of the inner and outer root sheaths, as well as the hair shaft. 
As a whole, the HF can be divided into five sections when starting at its bottom and going up towards 
the skin surface: the bulb, the suprabulbar region, the central region, the isthmus, and the 
infundibulum (Figure 2).  
1.2.1.1. The Bulb and Suprabulbar Region 
The bulb represents the deepest, most distal part of the HF and is the site where biological synthesis of 
the hair takes place. It consists of the hair matrix (i.e. the germinative zone) and the dermal papilla, 
which is mainly composed of mesenchymal cells, and is believed to regulate the growth cycle of the 
hair [12]. The matrix cells
2
 ultimately differentiate into the inner root sheath (IRS) and the hair shaft 
(see Section 1.2.2.2 & 1.2.2.3, respectively) [13].  
The suprabulbar region is located just superior to the bulb. This is the site where the various layers of 
the hair begin to differentiate, and is also known as the keratogenous zone. As cell division unfolds 
and the matrix cells proliferate rapidly, they move up into this zone where they increase in volume, 
elongate, become larger, and begin to ‘keratinize’ [14]. Furthermore, melanin synthesis by 
melanocytes begins here, resulting in pigmentation of the hair. 
1.2.1.2. The Isthmus and Central Region 
The isthmus section of the HF marks its most superior point at the insertion point of the sebaceous 
gland, and reaches down to the insertion point of the arrector pili muscle (see Figure 2), including the 
                                                     
2
 The distal matrix cells are also sometimes referred to as trichocytes 
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so-called bulge of the HF [13, 15]. This region is of special interest to many researches, as the bulge is 
known to contain putative follicular epithelial and melanocytic stem cells which are, for example, 
involved in epithelial regeneration during wound healing [16-19]. Spanning from below the arrector 
pili muscle to the suprabulbar region of the HF is the so-called central region. In this region the hair 
undergoes its final stages of keratinization. 
 
Figure 2: Schematic overview showing the anatomy of the hair follicle. BL = basal cell layer of ORS, C = cortex of hair,     
cu = cuticle of the hair shaft, CL = companion cell layer of ORS, CCL = central cell layer of ORS, DP = dermal papilla, He = 
Henle’s layer of IRS, Hu = Huxley’s layer of IRS, icu = cuticle of IRS, IRS = inner root sheath, M = medulla of hair, MC = 
matrix cells, ORS = outer root sheath, SC = stratum corneum (not drawn to scale).  
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1.2.1.3. The Infundibulum 
The infundibulum is the uppermost segment of the HF starting at the epidermis, and reaching down to 
the beginning of the sebaceous duct. It is a continuation of the interfollicular epidermis, thus it 
represents the interface between the skin epithelium and the outside world. Even though this part of 
the HF is often regarded simply as a canal whose duty is to only guide the outwards passage of the hair 
shaft, it actually harbors a rich microflora. Many cells are found in this region dealing, among many 
other functions, with antigen recognition and presentation due to a dense network of antigen 
presenting cells [20-22]. Since the HF is an invagination of the epidermis, and the infundibulum is the 
uppermost region of it (see Figure 2), the SC is still present and intact in the upper region; however, in 
the lower part of the infundibulum it is already less developed and more permeable [23]. 
1.2.2. Compartments of the Hair Follicle 
The HF itself is composed of several morphologically distinct and concentrically organized 
compartments: the outer root sheath (ORS), the inner root sheath (IRS), and the hair shaft (see Figure 
2 & Figure 3).  
 
Figure 3: Coss-sections stained using haematoxylin & eosin (H&E) depicting the central region (a) and the bulb (b) of a 
terminal anagen hair. C = cortex Cu= cuticular layer of hair shaft, He = Henle’s layer of IRS, Hu = Huxley’s layer of IRS, 
icu = cuticle of IRS, IRS = inner root sheath, M = medulla, MC = matrix cells. 
 
All three compartments are further subdivided into sub-compartments, which will be explained in 
detail below. Using protein gel electrophoresis, a lot of insight was gained on the morphologic 
diversity of the HF in the past, as the diverse protein pattern of keratins (hair keratins vs. epithelial 
keratins) was shown to mirror this situation nicely [24].  
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1.2.2.1. Outer Root Sheath  
The outer root sheath (ORS) comprises the most peripheral epithelial cell layers of the follicle and is 
contiguous with the interfollicular epidermis [13]. It envelopes almost the entire HF (except the 
dermal papilla) and contains various cell types including melanocytes, Langerhans cells (dendritic 
cells responsible for antigen presentation; mostly located in infundibulum), and Merkel cells [9]. Thus, 
this section allows the HF to act as a sensory organ, as well as being the immunological gate-keeper 
for the skin.  
It is structurally divided into three layers (Figure 2). The outermost layer is known as the basal cell 
layer (equivalent to the basal cell layer of the epidermis), followed by the central cell layer (CCL) and 
the innermost monolayer, known as the companion cell layer (CL).  
1.2.2.2. Inner Root Sheath 
As previously described, the inner root sheath (IRS) is a development which stems from the matrix 
cells in the bulb of the HF. It starts at the bulbar zone of the HF and abruptly desquamates in the 
middle of the isthmus [14, 24]. The IRS connects distally to the CL of the ORS and proximally to the 
hardening hair fiber. It can yet again be divided into three layers: Henle’s layer, a monolayer located 
on the outside of the IRS connected to the CL of the ORS, Huxley’s layer in the center, and the cuticle 
of the IRS which is in close contact with the hair shaft (Figure 2 & Figure 3). Interestingly, the order 
of differentiation and keratinization undergoes a different sequence for these three compartments. 
Differentiation starts in Henle’s layer, proceeds to Huxley’s layer and ends with the cuticle [25]. 
Keratinization, on the other hand, begins in Henle’s layer, followed by the cuticle and lastly occurs in 
Huxley’s layer.    
1.2.2.3. Hair Shaft 
The hair shaft is the other main product of the undifferentiated matrix cells in the bulb. It is a strong 
fiber which is composed of terminally differentiated, dead keratinocytes. Going from the inside to the 
outside it can be structurally divided into the medulla, comprised of living polygonal cells, the cortex, 
and, most peripherally, the cuticle of the hair shaft (Figure 2). 
1.3. Tight Junctions  
Tight junctions (TJs) are barrier-forming paracellular junctions composed of various TJ 
transmembrane proteins (e.g. claudins, occludin, tricellulin, and junctional adhesion molecules 
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(JAMs)), cytoplasmic linker or adaptor proteins, which connect them to the actin cytoskeleton (e.g. 
ZO-1, -2, -3, cingulin, MAPP1), and signaling molecules (e.g. Protein kinase C) which control the 
paracellular transport (see Figure 4) [26-28].  
They were first identified on the ultrastructural level by Farquhar and Palade in 1963 in various simple 
epithelia [29]. In that study, they were shown to be part of a tripartite junctional complex consisting of 
zonula occludens (tight junctions), zonula adhaerens (intermediary junctions), and macula adhaerens 
(desmosomes). Although differing in the precise arrangement of the complex, the existence of TJs was 
already then shown in epithelia of many organs including the stomach, intestine, gall bladder, as well 
as uterus or oviduct epithelia.  
Out of the three mentioned junctional complexes (tight junctions, intermediary junctions, 
desmosomes) TJs are the most apical ones in simple epithelia, while being intermingled in complex 
endothelia, e.g. brain endothelia [27]. Under normal conditions an intercellular membrane space is not 
present between two neighboring cells at TJ positive sites, which can be visualized in transmission 
electron microscopy as a very close contact between the neighboring cells. Therefore, they are also 
often referred to as “sites of fusion” or “kissing points” [30, 31].  
 
 
Figure 4: Schematic representation of the basic structural transmembrane components of tight junctions. Claudins and 
Occludin/tricellulin as well as JAMs are transmembrane proteins. ZO-1, ZO-2 and cingulin provide a direct link to the actin 
cytoskeleton (modified version of image in [31]). 
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For the purpose of this doctoral thesis, the focus was placed on five specific tight junction proteins: 
Occludin (Ocln), Claudin-1 (Cldn-1), Cldn-3, Cldn-4, and zonula occludens protein 1 (ZO-1). 
1.3.1.  Occludin 
Occludin (Ocln), a member of a larger protein family called TAMPs (TJ associated Marvel proteins 
(Marvel: (Myelin and Lymphocyte-related proteins for vesicle trafficking and membrane link)) has 
been under investigation regarding its exact function and role in TJs [32] for many years. It is a four-
pass integral membrane protein (ca. 65 kDa) involved in signaling pathways and TJ assembly [33]. It 
was the first TJ protein to be discovered in 1993 by Furuse and colleagues [34]. Ocln is known to 
interact with the actin cytoskeleton by binding actin directly, or via adapters like ZO-1, -2, -3, or 
cingulin [28]. During TJ assembly and disassembly it can also associate with enzymes which induce 
post-translational modifications (phosphorylation, dephosphorylation, or ubiquitination). In order to 
determine whether this protein is not only structurally important, but also essential for intact barrier 
properties, various different studies dealing with Ocln modifications have been performed in the past. 
These TJ studies of structure and functionality ranged from Ocln over-expression to knock-out 
mutations in mice. While the over-expression studies revealed that Ocln is important for TJ assembly, 
and that TJ barrier integrity may even be enhanced [35], the results from the knock-out studies 
surprised the investigators. TJs did not appear to be morphologically affected by the lack of Ocln, and 
barrier function of the intestinal epithelium, evaluated based on transepithelial resistance (TER), was 
normal [36, 37]. There are two possible explanations for this. Either Ocln is dispensable for TJ barrier 
function, or, in contrast, Ocln is so important that there is a backup system in charge of compensating 
for it by using other proteins during development. Interestingly, however, histological examinations 
revealed numerous abnormalities in various organs of these knock-out mice; most likely due to 
dramatic changes in gastric morphology and secretory function hinting at additional, non-barrier 
related functions.  
In the skin, Ocln has been shown to be confined to the granular cell layer, or stratum granulosum [38]. 
This restricted distribution was also seen in human HFs [30]. By means of immunostaining, this TJ 
protein was localized in the companion cell layer (CL) and neighboring cells of the ORS in the 
isthmus and central region, in the CL of the lower central and suprabulbar region, and completely 
negative in the ORS of the bulb. The IRS of human HF was positive for Ocln from the bulbar to the 
lower central region.  
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1.3.2. Claudins 
Cldn-1, -3, and -4 are also integral membrane proteins which span the lipid bilayer four times with the 
N- and C-termini oriented towards the cytoplasm and two extracellular loop domains [39]. They 
belong to a family of (as of now) 27 members, the first ones also identified by Furuse et al. in 1998 
[40]. Compared to Ocln they are smaller in size (22-27 kDa) and give rise to completely different 
amino acid sequences. Especially Cldn-1 and Clnd-4 have been recognized as important regulators of 
paracellular transport in various epithelia. Their C-terminus binds to the PDZ domains
3
 (for detailed 
review please refer to reference [41]) of TJ adapter proteins like ZO-1 and cingulin, which allows 
them to indirectly interact with the actin cytoskeleton. In the past, many studies have involved the 
over-expression, knock-down, or knock-out of claudins, which all consistently resulted in large 
changes in paracellular permeability in simple epithelia. While the role of Clnd-1 regarding skin 
barrier function in mice was shown to be vital (see Section 1.3.4), involvement of TJ protein Cldn-4 in 
barrier function has to date only been demonstrated in lung cells. There, inhibiting this protein resulted 
in an increase in paracellular permeability in healthy lung, yet an increase in Clnd-4 expression was 
seen in a lung injury model [42]. Thus, normal expression levels of this protein seem to be extremely 
important regarding its correct function.  
Distribution of these two TJ proteins in skin differs greatly. While Cldn-1 is localized throughout the 
entire viable epidermis, Cldn-4 is mainly found in the stratum granulosum and upper stratum 
spinosum [43]. In human HF their localization has also been investigated and Cldn-1, similarly to the 
epidermis, is found in all layers of the ORS throughout the HF [30]. In the IRS, Cldn-1 is mainly seen 
in Henle’s and Huxley’s layers from the bulb to the lower central region. Localization of Cldn-4 in 
human HF is confined to the CL of the ORS and some neighboring cells. In the lower central region, 
suprabulbar region and bulb Cldn-4 staining is present in the CL of the ORS. IRS staining of Cldn-4 is 
positive in Henle’s and Huxley’s layers except for the highly keratinized cells.  
The last claudin discussed in this work, Cldn-3, has been shown to be a good indicator and target for 
detecting and targeting cancers of various types, however its role as a tightening agent for functional 
TJs is only assumed as of now [44-47]. Nonetheless, as it has previously been shown to be expressed 
and localized in mouse skin and HFs [48], we chose to investigate its distribution and involvement in 
barrier function here as well. 
                                                     
3
 PDZ domains are protein-interaction domains often found in multi-domain scaffolding proteins 
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1.3.3. ZO-1  
Connecting the integral membrane proteins to the underlying actin cytoskeleton, plus other signaling 
proteins, is a meshwork of densely packed peripheral proteins like zonula occludens protein 1 (ZO-1), 
ZO-2, and ZO-3.  They are members of the MAGUK (membrane-associated guanylate kinase) protein 
family, and represent an essential subgroup of the PDZ proteins of TJs [49]. It has been shown that 
interaction between ZO-1, ZO-2 and claudins plays an essential role in assembling TJ strands, and, 
with that, give rise to TJ barrier function [50].  
In human skin, ZO-1 is located in the stratum granulosum and the upper layer(s) of the stratum 
spinosum [30]. Expression and localization of this TJ protein was also investigated in human HFs, 
where it was shown to be present mainly in the CL of the ORS and somewhat more weakly in 
surrounding cell layers from the isthmus down to the suprabasal region. The IRS from the bulbar 
region to the lower central region also gave rise to positive staining in Henle’s and Huxley’s layers, 
except for highly keratinized cells.  
1.3.4. Tight Junctions as a Barrier in Skin 
The role of TJs as a barrier in simple epithelia and endothelia has been characterized in detail over the 
years. There they have been shown to regulate the transit of ions and macro-molecules via the 
paracellular route [49, 51]. This barrier function can, in part, be measured as an electrical resistance 
(transepithelial resistance, TER), and is a prerequisite for directional transepithelial transport [41]. 
Furthermore, TJs have been attributed a so-called ‘fence function’ within the cell membrane because 
of their capability to mechanically restrict diffusion of lipids and proteins by separating the two 
components of the plasma membrane into the apical and basolateral compartment [31, 38]. This, in 
turn, results in cell polarity. However, their involvement in this ‘fence function’ was challenged 
recently [52].  
The existence of typical barrier-forming TJ structures in the epidermis of fish, amphibians and reptiles 
has been known for decades. Yet, the existence of functional TJs in mammalian epidermis was for 
long a topic of general disagreement (e.g. [53-56]). Only in recent years first barrier properties were 
confirmed [43, 57, 58]. A continuous, intact barrier to an extracellular tracer molecule (Sulfo-NHS-
LC-Biotin (Biotin-SH; 557 Da); further explained in section 1.6) was demonstrated in healthy human 
skin at Ocln and Cldn-1 positive sites in the stratum granulosum [43, 59-61]. Moreover, Cldn-1 was 
shown to have a great impact on paracellular permeability of the stratified epithelium of the skin, as 
Cldn-1 deficient mice died of dehydration within one day after birth [62, 63]. Also in human 
keratinocytes the importance of this specific TJ protein (Cldn-1) for maintaining an intact epidermal 
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barrier was shown as knock-down experiments revealed a decrease in the TER, plus an enhanced 
paracellular tracer flux for sodium fluorescein [64]. Similarly, a knock-down of Ocln resulted in 
decreased TER values in human keratinocytes [64]. Thus, in healthy skin, the previously described SC 
and epidermal TJs seem to interact in a dynamic manner to assure that a formidable barrier is given.  
The importance of this TJ barrier, or rather the lack thereof, has further been elucidated in various skin 
diseases. In atopic dermatitis, the most common inflammatory skin disease, consensus has long been 
reached that the SC barrier is dysfunctional as a result of a variety of possible defects (e.g. decreased 
levels of SC lipids [65]). In 2011, De Benedetto et al. showed significantly reduced expression of TJ 
proteins Cldn-1 and Cldn-23 in non-lesional atopic dermatitis skin in a Northern American Cohort 
[66]. This could, however, not be confirmed in a Central European Cohort. Nonetheless, it was 
recently revealed that Cldn-4 is upregulated in non-lesional skin and Cldn-1 is down-regulated in 
lesional skin [67]. Thus, in general, changes of TJ composition can be observed in atopic dermatitis. In 
Psoriasis, a skin disease characterized by hyperproliferation of keratinocytes, a broader localization 
was observed for TJ proteins Ocln, ZO-1 and Cldn-4 when compared to normal skin, while Cldn-1 and 
Cldn-7 were down-regulated [68]. This, again, highlights the involvement of TJs in skin barrier 
function. 
As was shortly described for each individual TJ protein above, Brandner et al. performed a study in 
2003, investigating the expression and localization of various TJ proteins (ZO-1, claudin-1, claudin-4, 
claudin 12, claudin 17, occludin) in human HFs [30]. In this study all proteins were localized 
throughout the entire HF, reaching from the infundibulum down to the bulb, thus including areas 
where no SC is present. These results were extremely important as they suggest that TJs in the HF, 
similarly to TJs in the epidermis, may serve as biological barrier. However, the fundamental 
functionality of mammalian follicular TJs with respect to barrier properties had not been investigated 
until now. 
1.4. Transport Pathways through the Skin 
The transdermal delivery route is a very attractive technique to administer drugs for several different 
reasons: 
 it provides an alternative for drugs which would normally undergo a significant  
first-pass effect in the liver, 
 it usually entails a non-invasive approach resulting in increased patient  
compliance, 
 
 drug release can be modified in order to optimize therapy outcome [69]. 
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Even though epidermal TJs have been given increased attention over the last years regarding their 
potential as a second invasion barrier, in healthy skin the SC is still considered the bottleneck, or 
limiting barrier, for invasion of drugs. Consequently, drugs have to surpass this brick-and-mortar 
structure in order to reach the viable epidermis and/or the blood circulation. There are two basically 
different, yet feasible, non-destructive invasion pathways through the skin which have to be 
considered (see Figure 5):  
 Diffusion across the intact SC, also known as the transepidermal route. 
 Invasion via skin appendages such as hair follicles (or glands). 
1.4.1. Transepidermal Route 
The transepidermal route can be further subdivided into the transcellular and intercellular pathways 
(Figure 5). Both involve the passage of an exogenous substance from the surface of the skin into the 
SC under the influence of a concentration gradient and subsequent diffusion through the various skin 
layers [70].  
 
Figure 5: Graphic displaying the three discussed transport pathways through the skin: transcellular diffusion, intercellular 
diffusion, and the transfollicular route. Not drawn to scale. 
 
The transcellular route represents the more direct route through the SC into the viable epidermis, as 
can be seen in Figure 5. Nevertheless, this pathway is normally regarded as negligible because 
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substances will have to undergo substantial partitioning between the lipid bilayer and the rather dense 
and hydrophilic corneocytes, resulting in highly reduced diffusion and penetration [71]. 
The intercellular (or paracellular) route is thus considered the predominant diffusion route for most 
substances, and leads through the lipid matrix located between the corneocytes. As this matrix is 
composed of liquid crystalline structures, the intercellular route provides lipophilic as well as 
hydrophilic domains, offering the possibility for substances of both natures, lipophilic and hydrophilic, 
to passively diffuse along this pathway. Although this path is very torturous and much longer than the 
direct transcellular route (~ 500 µm in length as opposed to approximately 20 µm [72]), the diffusion 
is relatively fast and can easily be modified by aplying chemical penetration enhancers like propylene-
glycol, DMSO, or others [73-75]. 
One thing to keep in mind for both transepidermal routes, however, is that passive diffusion through 
the SC without any penetration enhancers only occurs for relatively small molecules (< 500 Da) of a 
rather lipophilic nature (log P value ranging from 1-5), significantly limiting the possibilities of 
application. Due to these physicochemical restrictions, the encapsulation of various substances into 
nano- or micro-sized carriers, and subsequent transdermal delivery, has also been under investigation 
(for a comprehensive review on this topic the reader is kindly referred to [76]). Consensus has 
meanwhile been reached that particles (polymer-based or made of zink oxide) > 20 nm are unable to 
cross the SC and hence are unable to reach the viable part of the epidermis [77, 78]. While this is 
comforting regarding the safety aspects of nanomaterials which should not enter the skin, it restricts 
their use for drug delivery through the interfollicular epidermis.  
1.4.2. Trans-follicular Pathway 
In the past, the trans-follicular pathway was considered only a secondary route of transdermal 
penetration, as in average only 0.1% of the skin surface is affected [79]. However, this rationale was 
quickly changed when researchers from France demonstrated that percutaneous penetration of various 
drugs was significantly higher in hairy mice relative to hair-less mice [80]. In the years to come, other 
groups followed their lead and were able to show similar results on human skin in vivo [81, 82].  
In the early 2000s, many researchers also focused their efforts on the development of nanocarriers and 
the possibility of targeting the HF using these drug delivery systems. As the HF represents an 
invagination, or extension, of the epidermis it gives rise to an increased available surface area, much 
higher than what was initially assumed. Furthermore, this region is surrounded by numerous blood 
capillaries and immunocompetent cells, facilitating the absorption of drugs and/or immunologic 
response [21, 22].  
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There is convincing evidence that particles ranging between ~100-900 nm can penetrate into HFs, 
even more pronounced than dissolved molecules [83, 84]. Additionally, depending on particle 
characteristics like size, charge, or surface functionalization, differences in the degree of follicular 
uptake were observed [84-86]. In 2006, Lademann et al. also discovered that the HF shaft acts as a 
long-term reservoir of these particles for a maximum of 10 days [87]. This new information was 
revolutionizing, as it means that upon accumulation in the hair shaft, drugs can be released over time 
and continuously diffuse to the surrounding follicular and perifollicular cells (e.g. immunocompentent 
cells), or cross the capillary walls and reach the blood stream. 
Current research efforts in the field of targeted delivery of drugs to the HF span a broad field of 
different applications, ranging from cosmetic products for acne treatment to non-invasive 
transcutaneous vaccination [88-92]. In the dermatologic practice, this route of penetration would also 
be of benefit for the administration of e.g. glucocorticosteroids. These drugs entail a wide scope of 
skin disorders, ranging from atopic dermatitis or psoriasis, to various inflammatory-based scalp 
diseases for which targeting the HF is one of the goals, yet biggest challenge [93-97]. However, potent 
glucocorticosteroids are also known to bring along a wide range of side effects, even when only 
applied topically [98, 99]. Fortunately, the developments in nanotechnology over the years have not 
only enabled researchers to target specific sites in the body by using functionalized particles, but many 
researchers have also been able to show that the encapsulation of various drugs allows for a sustained 
and controlled release over time [100-106]. Thus, the combination of both, nanoparticles capable of 
releasing the drug in a controlled manner and simultaneous targeting of the HF would be of great 
benefit and immensely increase the possibilities of treating the above mentioned diseases.  
1.4.2.1. The Pig as an in vitro Model 
For skin absorption and percutaneous penetration studies, porcine ear skin has been evaluated as a 
valuable in vitro model [107]. Specifically for ex vivo follicular uptake studies, porcine ear skin has 
even become known as the ‘gold standard’ and may be considered superior to human skin for the 
following reasons: for one, it is difficult to obtain sufficient amounts of human tissue at the time points 
when they are needed for experiments, while this is not the case for porcine ear skin. Secondly, and 
more importantly, HFs in human skin are known to contract immediately upon excision, whereas in 
porcine ear skin the cartilage prevents contraction of tensile fibers, and therefore no subsequent 
closure of the HFs occurs [108]. Nevertheless, applicability and a good correlation between in vitro/ex 
vivo studies on pig and in vivo studies on human needed to be investigated in order to establish 
suitability of this model.  
Anatomically, HFs of both human and porcine descent, show an inner and an outer root sheath, a 
sebaceous gland associated with the HF, and sweat glands in the dermal layer [109, 110]. The 
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thickness of the SC and the viable epidermis, as well as density and follicle diameter of the terminal 
hairs, were also found to be similar [109].  
In 2014, a series of experiments on human forearm skin and pig ear skin was performed using five 
different types of nanoparticles in order to determine the correlation of in vivo and in vitro follicular 
uptake data, respectively [86]. They concluded that, even though the pig ear model slightly 
overestimated differences between the particles, the general trend observed was similar for both 
species (in vitro-in vivo correlation: r
2
 = 0.987).  
Based on all the published data discussed, one can assume that the porcine ear skin model is a reliable 
tool for mimicking the in vivo situation in follicular penetration studies. Nonetheless, further 
comparability studies concerning e.g. chemical components in, or TJ protein distribution throughout 
human and porcine HFs would only strengthen this assumption. 
1.5. Experimental Methods to Investigate Skin 
Permeation and Follicular Uptake 
In vitro permeation studies on skin, as well as in vivo or ex vivo follicular uptake studies on human or 
pig skin, respectively, have been optimized over the past couple of decades in order to get robust and 
most reliable data. In the next section, two state of the art techniques used by researchers all over the 
world, as well as for this thesis, will be introduced shortly. 
1.5.1. The static Franz Diffusion Cell 
For skin permeation experiments, the state of the art technique is the Franz Diffusion cell model. In 
this experimental setup, which is depicted in Figure 6, the donor and acceptor compartments are 
generally separated by a membrane, which usually consists of one or more layers of excised skin (e.g. 
whole skin, heat-separated epidermis, SC only). The cells are typically made of glass and can be 
classified into flow-through, or static cells [111]. Only the latter will be explained in detail, as the 
research performed for this doctoral thesis involved the static Franz Diffusion cell only. 
Before starting the experiment, one must be sure that the composition of the acceptor fluid does not 
limit the extent of permeation of the analyte, thus total solubility should be guaranteed. Moreover this 
fluid should not affect nor alter the integrity of the membrane used; meaning normal permeability 
properties of the skin should be given [112-114].  
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Upon addition of the test substances in a desired formulation (e.g. solution/suspension, semisolid 
preparation, etc.) into the donor compartment, samples are withdrawn from the sampling port at pre-
determined time intervals and subsequently analyzed for cumulative amount of permeated substance. 
In order to guarantee a homogeneous distribution of drug, a magnetic stirrer is placed into the acceptor 
compartment before begin of the experiment. Furthermore, the whole system is thermostatically 
controlled throughout the entire length of the experiment in order to mimic the in vivo situation as 
good as possible. 
 
Figure 6: Sketch of a static Franz Diffusion cell (modified version of image from [111]) 
Based on the amount of substance added into the donor compartment, one can differentiate between 
two scenarios: finite and infinite dosing. For finite dosing only a limited amount of substance (< 10 
µl/cm
2 
of a liquid formulation, or 1-5 mg/cm
2 
of a semisolid formulation according to the Organisation 
for Economic Co-Operation and Development (OECD) guidelines on percutaneous absorption studies 
[114]) is added to the donor compartment. In contrast, infinite dosing means that the applied dose is so 
large that for the length of the experiment an unlimited amount of substance is available to permeate 
from the donor into the acceptor compartment. Under the latter conditions the data may permit the 
calculation of a permeability constant (Kp) [114]. The amount of substance left in the skin is usually 
not quantified for this experimental set up. 
1.5.2. Differential Stripping Method 
The Differential Stripping (DS) method is the most straightforward technique to determine follicular 
uptake quantitatively [86]. For reasons mentioned above the in vitro studies are performed on porcine 
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ear skin. Thus, the allocation of porcine ears is required, and only ears with immaculate skin surface 
(no abrasions, inflammation, etc.) are to be used.  
In the past, various different approaches had been attempted in order to distinguish between the 
transepidermal pathways and follicular penetration. These approaches included (i) confocal laser 
scanning microscopy methods for investigating the distribution of various fluorescently-based 
substances in different skin layers and/or appendageal structures [115], or (ii) analyzing histology-
derived sections [116, 117]. The term ‘Differential Stripping’ was first introduced in 2005 by 
Teichmann et al., and described the combination of the tape stripping technique (cleaning of skin 
surface) with cyanoacrylate skin surface biopsies (removing the follicular cast) [118, 119]. However, 
back then the method was rather a qualitative analysis than a quantitative way of determining 
follicular penetration. In 2014, Raber et al. modified and optimized this method, and ultimately 
obtained a protocol which made it feasible to fully quantify follicular uptake of nanoparticles [86].  
The first step of this protocol entails applying the formulation (e.g. solution, nanoparticles in 
suspension or nanoparticles in a hydrogel) onto a predetermined area on the outer auricle of the pig ear 
followed by an optional massage, depending on the experimental setup. After a predetermined 
incubation time under constant temperature conditions, ten subsequent tape strips are taken in order to 
clean the skin surface and remove the SC layer by layer. To analyze the extent of follicular drug 
penetration, cyanoacrylate skin surface stripping is performed. This step implies the application of 
superglue to the pretreated skin area covered by a tape strip. Upon polymerization of the glue, the tape 
strip is quickly peeled off, removing the entire follicular cast [118]. For quantification and mass-
balance purposes the substance of interest is extracted from the tape strips, cyanoacrylate biopsies, as 
well as all application devices, and skin rest are analyzed for drug content via an analytical method of 
choice. 
1.6. Experimental Method to Determine Tight 
Junction Functionality 
Measuring TJ barrier integrity has become the main method for determining whether TJ structures are 
indeed functional. Several different methods have been employed for investigating TJ functionality, as 
has been mentioned shortly above.  
Under cell culture conditions, barrier properties of TJs have mostly been evaluated based on electrical 
and flux approaches in which the transepithelial resistance (TER) of the monolayer, or transport of 
model substances from the apical into the basolateral compartment were measured, respectively 
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[e.g.47, 120, 121, 122]. However, one has to be aware that the TER measures the ion barrier of the 
whole cellular sheet, i.e. it takes paracellular as well as transcellular ion flux into account [e.g.123] 
In 1997, Chen et al. introduced a new technique of measuring TJ tightness by using a  polar, biotin-
labeled molecule called succinimidyl-6-(biotinamido)hexanoate (NHS-LC-Biotin) of 455 Da [59]. In 
order to obtain better solubility, this compound was later modified by adding a charged sulfo-NHS 
group, as is depicted in Figure 7 [124].   
 
Figure 7: Structure of tracer molecule Sulfo-NHS-LC-Biotin (557 Da) 
Due to its structure, this molecule (with and without the added sulfo group) does not enter intact cells 
and does not penetrate through intact TJs, yet it irreversibly binds primary amine groups of proteins, 
which makes it easily traceable. Its usefulness in determining TJ tightness, and thus functionality, has 
been demonstrated in various studies over the years. In 2002, Furuse and colleagues were able to 
reveal an inside-out barrier stop to this tracer molecule in newborn mouse skin at Ocln-positive sites, 
whereas in Cldn-1 deficient mice this stop was diminished [58]. Shortly thereafter, various other 
groups were able to reproduce these experiments on human and porcine skin demonstrating its 
applicability for determining TJ barrier function in various species under various conditions [125-
127].   
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1.7. Aims of This Work 
Over the last decade, the surging interest of nanoparticle-based drug delivery to the hair follicle has 
opened many novel possibilities to researchers all over the world. Especially the field of 
transcutaneous vaccination has gained a lot of promising insights about new applicable formulations 
which embrace a non-invasive approach by using this technology. As already mentioned in previous 
chapters, porcine ear skin is widely accepted as the ‘gold standard’ for follicular penetration studies. 
Nonetheless, the crucial question as to whether this pig ear model, or more specifically the porcine 
hair follicle, is indeed equivalent in e.g. chemical composition or tight junction protein distribution, 
and thus suitable for representing the in vivo situation in human skin, remains to be further elucidated. 
Moreover, the biology of the hair follicle itself needs further clarification. Specifically the question as 
to whether follicular tight junctions are functional with regard to barrier properties, and if so, the 
ability of modulating, or opening this potential biological barrier, has not been addressed up to now. 
Also, not much is known about the fate of nanomaterials (i.e. toxins or drug delivery systems) upon 
penetration into the hair follicle. Questions about whether these particles stay intact or immediately 
disintegrate upon penetration, what specific region in the hair follicle they reach, or what types of 
barriers (besides the well-known stratum corneum) they may encounter, remain to be answered. 
Lastly, it is important to further explore the types of effects concerning release, transdermal 
permeation, and follicular uptake that can be observed as a result of encapsulating drugs into various 
carrier systems.  
In order to address these questions, the aims of this thesis were (i) to first evaluate and compare the 
chemical composition of porcine and human hair follicles using confocal Raman microscopy, and 
assess intactness and distribution of these components in cyanoacrylate skin surface biopsies in order 
to determine if, in fact, the entire follicular cast is removed during this process; (ii) to investigate 
expression and localization of tight junction proteins in porcine hair follicles via qPCR & 
immunohistochemical staining in order to compare results to previously published data in human and 
thereby determine equivalency, plus to investigate functionality of these structures using the tracer 
molecule Sulfo-NHS-LC-Biotin, and the ability to modulate barrier properties; (iii) to gain insights on 
follicular penetration depth of model polymeric nanoparticles via transmission electron microscopy, 
and simultaneously determine whether particles stay intact upon penetration or not; (iv) to study the 
effect of nanoencapsulation on the release, follicular uptake, and transdermal permeation  of 
Clobetasol, a potent glucocorticosteroid, by using three different types of nanocarriers.  
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Based on these aims, the thesis will be organized into three main chapters: 
 
Chapter 2.1: Porcine Ear Skin as a Surrogate for Human Tissue: An Analysis using 
Confocal Raman Microscopy  
Chapter 2.2: Follicular Tight Junctions as a Biological Barrier 
Chapter 2.3: Nanocarriers for Optimizing the Balance between Interfollicular 
Permeation and Follicular Uptake of Topically Applied Clobetasol  
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2.1. Porcine Ear Skin as a Surrogate for Human Tissue: 
An Analysis Using Confocal Raman Microscopy 
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2.1.1. Abstract 
Hair follicles have recently gained increasing interest in the field of transdermal drug delivery. They 
have shown to provide a facilitated uptake into the skin, as well as a high potential to enable a drug 
depot. In this area of research, excised porcine ear skin is widely accepted as an in vitro model to 
assess penetration of drug delivery systems into hair follicles. However, a comparison of porcine and 
human hair follicles in terms of chemical composition has not been reported so far. In this study, 
confocal Raman microscopy was applied as a chemically selective imaging technique in order to 
compare human and porcine hair follicle composition, and to visualize individual component 
distribution within follicular cross-sections. Based on measured and processed human and porcine 
Raman spectra, optical similarity was successfully confirmed for both species. Moreover, 
cyanoacrylate skin surface biopsies, which are generally applied to measure the extent of follicular 
penetration, were imaged using a novel complementary analytical approach which combines confocal 
Raman microscopy and optical profilometry. This all-encompassing analysis generates a 3-D image 
which permits investigation of component distribution, and intactness of the removed hair bulb. 
Overall, confocal Raman microscopy proves its high potential as a non-invasive and chemically 
selective analytical approach for the investigation of trans-follicular drug delivery. 
2.1.2. Introduction 
Many different studies in the field of pharmaceutical technology have recently demonstrated the 
importance of the transfollicular route for drug administration, especially with regard to drug delivery 
systems in the nano-sized range [88-90]. Varying in applicability from treating skin or hair diseases to 
transcutaneous vaccination, the HF and its ability to provide a depot effect (i.e. sustained release of 
drug) has widened the spectrum of new potential drug delivery systems [87, 91, 92].  
In Chapter 1 it was already discussed that the general application of the pig ear as an in vitro model for 
these types of follicular uptake studies (due to closure of the HF in excised human skin [108]) has 
been widely accepted. It has also been shown that both species express anatomically equivalent 
structures and compartments in the terminal anagen HF, ranging from the inner and outer root sheaths 
and their individual subdivisions, to an attached sebaceous gland and arrector pili muscle. In addition, 
thickness of the SC and the underlying viable epidermal layers, as well as follicle density and 
thickness are similar in both species [109, 110]. Also, concerning experimentally obtained data on 
porcine (ear) skin, many studies on skin absorption, percutaneous penetration, as well as follicular 
uptake have been evaluated and deemed suitable when compared to equivalent studies on human 
tissue [86, 107, 109, 128]. By using the so-called skin sandwich method, it was shown that porcine HF  
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absorption of various solutes differing in their physicochemical properties mirrored previously 
accumulated absorption data on human tissue [129, 130]. 
Nevertheless, one specific comparison between the two species, which has not at all been discussed in 
literature up to now, is the composition of various follicular components, most importantly porcine 
sebum vs. human sebum. In humans, hamsters, rats, and mice the composition has previously been 
investigated and thoroughly characterized. It mainly consists of triglycerides, sterol- or wax-esters, 
diol-diesters, free sterols, and free fatty acids [129, 131]; only human sebum additionally contains 
squalene. Yet the composition of porcine sebum has not been examined at all. Considering, however, 
that the sebum represents the release medium for drugs delivered via the transfollicular route, we 
considered this information, or the lack thereof, very important and necessary to investigate further. 
A suitable technique to obtain an all-encompassing analysis concerning chemical composition of 
sebum and other major HF components, or visualization of spatially resolved component distribution 
(sample mapping) in porcine and human HFs, is confocal Raman microscopy. It is a chemically 
selective and non-destructive technique, thus optimal for biological samples. In the past, this technique 
has been used for qualitative analysis of substance penetration into the skin in vivo [132] and in vitro 
[133, 134], as well as for an evaluation of drug distribution on the skin surface, via sample mapping 
[135]. One study also dealt with the visualization and characterization of human hair revealing 
information about the secondary structure of proteins and the disulfide bridges [136].  
In this study, confocal Raman spectroscopy was applied in order to evaluate the chemical similarities 
between human and porcine HFs. Thus, the spectral properties of the four key follicle-associated 
components—hair, sebum, dermis and follicular epidermis—were analyzed and compared for both 
species. Furthermore, confocal Raman microscopy was used to image cross-sections of HFs, 
visualizing the individual component distribution. Finally, a novel complementary analytical approach 
combining confocal Raman and optical profilometry was applied to visualize cyanoacrylate biopsies 
of HFs, used to determine follicular uptake, in 3-D. 
2.1.3. Materials and Methods 
2.1.3.1. Materials 
Tesafilm® kristall-klar (Tesa, 33 m × 19 mm, cut to 30 × 19 mm sections) was obtained from Tesa 
AG, Hamburg, Germany. UHU superglue (UHU, blitzschnell Pipette) was kindly provided by UHU 
GmbH & Co, KG, Bühl/Baden, Germany. For nuclear staining, Mayer’s haematoxylin was purchased 
from Carl Roth GmbH+ Co. KG, Karlsruhe, Germany. 
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2.1.3.2. Porcine and Human Skin 
All porcine ears used for the herein described experiments were acquired from Emil Färber GmbH & 
Co. KG, a local slaughterhouse in Zweibruecken, Germany. The ears were excised immediately before 
the brewing step, and brought to the lab where they were thoroughly cleansed.  
The human skin used for all in vitro experiments was donated from the department of Plastic and 
Hand Surgery at the Caritaskrankenhause in Lebach, Germany. The study was performed on thigh skin 
which was acquired after plastic surgery performed on a 48 year old female donor who had previously 
consented to the donation. Immediately upon arrival of the skin, all subcutaneous adipose tissue was 
carefully removed, leaving only the dermis and epidermis for further investigations. The remaining 
skin was cut into pieces of 10 x 20 cm, covered in aluminum foil and stored at -20°C until further use. 
This study was approved by the ethical commission of Saarland, Germany (Aerztekammer des 
Saarlandes, 204/08). 
2.1.3.3. Longitudinal-Sections of Hair Follicles 
Longitudinal sections of HFs were obtained by excising 8 mm biopsies out of the 20 x 30 mm intact 
frozen human thigh skin sections or porcine ear skin. Next, cryosections with a thickness of 15 µm 
were cut using a cryomicrotome set at -20°C (MEV Cryostat, Slee, Mainz, Germany). For nuclear 
staining, sections were immersed in Mayer’s haematoxylin solution for 8 min followed by the blueing 
step which entails leaving the section under running water for 10 min.  
Visualization of the sections was performed on a Zeiss AXIO Scope A1 light microscope (Carl Zeiss 
Microscopy GmbH, Oberkochen, Germany), equipped with a digital camera (Axio-Cam ERc 5 s) for 
the taking of the images. Taken images were then edited and labeled using the software Zen lite 2011 
(Carl Zeiss Microscopy GmbH, Oberkochen, Germany). 
2.1.3.4. Cyanoacrylate Skin Surface Stripping 
As shortly described in Section 1.5.2 (General Introduction: Differential Stripping Method), 
cyanoacrylate skin surface stripping was performed by first applying a drop of UHU superglue onto a 
predetermined and pre-cleansed area on the outer auricle of the excised pig ear, followed by 
immediately placing a tape strip on top. Upon complete polymerization of the glue (approx. 10 min), 
the tape strip is quickly ripped off in one continuous movement, removing the entire content of the 
HF. For further analysis, all biopsies were fixed upside down onto a glass slide, leaving the HFs facing 
upwards. 
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2.1.3.5. Confocal Raman Microscopy & Optical Profilometry 
For all confocal Raman microscopic evaluation, the 15 µm sections, as well as the cyanoacrylate 
biopsies, were fixed onto calcium fluoride slides. Measurements were performed using a Witec alpha 
300R+ (WITec GmbH, Ulm, Germany). As excitation source a diode laser with an emitting 
wavelength of 785 nm was used. The power of the laser, placed right in front of the objective, was set 
to 50 mW, as this strength had previously been tested and shown to not harm biological tissue. The 
light microscopic images obtained were taken with a 10x objective (Epiplan Neofluar N.A. 0.5, Zeiss, 
Germany), whereas Raman single spectra and maps recording was done using a 50x objective 
(Epiplan Neofluar N.A. 0.8, Zeiss, Germany). In order to reject signals from out-of-focus regions, a 
confocal pinhole of 100 μm was employed. Raman spectra were recorded using a spectral resolution 
of 4 cm
-1 
over the range of 400 - 1780 cm
-1
. For a single spectrum, three measurements, which were 
taken over a 10-s integration time, were averaged. Raman mapping was done by collecting data at 
every 5 μm in x and y directions for a total of 10 s. The obtained data was then processed using WITec 
Project Plus software (WITec GmbH, Ulm, Germany). After applying a cosmic ray removal, a spectral 
baseline correction was performed using a polynomic fit. Finally, all spectra were normalized to the 
most intense peak (1430 to 1480 cm
-1
 representing ν(C─H)) [137]. 
For surface topography measurements, a True Surface Microscopy sensor incorporated in a Witec 
alpha 300R+ confocal Raman microscope (WITec GmbH, Ulm, Germany) was implemented. With a 
high accuracy of 1 µm, this sensor is able to resolve an elevation difference of 3 mm. Data points were 
collected every 5 μm in x and y directions, generating a lateral resolution equivalent to Raman 
mapping. 
2.1.4. Results & Discussion 
2.1.4.1. Comparison of Porcine and Human Hair Follicle 
The first part of this study was a composition comparison between human and porcine tissue of the 
four major chemical components (sebum, dermis, epidermis, hair) by confocal Raman spectroscopy. 
In Figure 8, longitudinal sections of porcine (a) and human (b) HFs are depicted, showing optical and 
dimensional similarities between the two species. For each image one can clearly differentiate between 
the hair (blue cross), the follicular epidermis (yellow cross; outer root sheath and inner root sheath are 
not differentiated here), deeper skin layers (green cross), and the sebaceous gland (red cross). To 
assess spectral comparability between the two species, Raman spectra were acquired for each of the 
four components in porcine and human HFs and are shown in (c) and (d), respectively. Here, the  
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Raman spectra measured at the areas marked by the colored crosses from (a) and (b) are shown in 
corresponding colors, thus human and porcine epidermal spectra are shown in yellow, the hair in blue, 
the dermis in green, and sebum in red.    
 
Figure 8: Microscopic pictures of porcine (a) and human (b) hair follicle cross-sections. Raman spectra obtained from the 
areas marked by the colored crosses displayed in corresponding colors from porcine (c) and human (d) follicles (image taken 
from [138]). 
The follicular epidermis spectrum is mainly composed of unspecific bands indicating protein at ~1003 
cm
-1
 (aromatic amino acids), 1440 cm
-1
  δ(CH), and at 1650 cm-1 (amide I) with keratin being the main 
component [137]. The dermis spectrum has two additional characteristic double peaks. The first one is 
located at 815 to 850 cm
-1
, and the second one at 920 to 940 cm
-1
.This specific pattern is representative 
for collagen, which is one of the main components of the dermis layer in the skin [139]. Concerning 
the hair spectrum, both species give rise to a prominent peak at 509 cm
-1
, known to be specific for 
disulfide bridges [136, 140]. These types of bonds are characteristic for keratotic tissue like hoof, 
horn, and hair.   
For an evaluation concerning similarity of the recorded spectra from both species, a statistically robust 
method was necessary. Thus, spectral subtraction was performed, followed by a calculation of the area 
under the curve (AUC) of the obtained graphs. For the references, three spectra of each component 
from varying positions were subtracted from each other. The resulting graphs specify the internal 
spectral variability for each individual component. Figure 9(a) displays these graphs for hair (blue), 
follicular epidermis (yellow), dermis (green), and sebum (red). The 95% confidence interval (CI) of  
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spectral similarity for each of the four components was then calculated based on the absolute AUC of 
the spectral subtraction graphs. In the last step, the component spectra of human and porcine HFs were 
subtracted from each other and the resulting AUC was calculated. The values for all AUCs, along with 
the confidence intervals obtained, can be found in Figure 9(b). A significant difference was observed 
for the hair, which displayed a much higher AUC (49,03) than the reference (27,99). However, as can 
be seen in Figure 9(c), upon subtraction of the two spectra only high noise, yet no major differences, 
was observed. Moreover, no significant difference was detected for the follicular epidermis or the 
dermis. The sebum was analyzed extra carefully, as it represents the potential release medium for drug 
delivery systems. Yet, between human and porcine sebum, no significant difference was observed. All 
minor discrepancies were only intensity related and thus negligible concentration differences of sebum 
components. For this study, the inter-individual variability of porcine and human HF composition was 
not taken into account, as it would have been necessary to test an immense number of individuals to 
gain valid results. However, by means of Raman spectroscopy, chemical composition of the four main 
HF constituents were analyzed and evaluated, confirming similarity between the two species. 
 
Figure 9: (a) Spectral subtraction graphs derived from porcine and human Raman spectra of the four main chemical 
components. (b) Statistical evaluation of the absolute area under the curve (AUC) of the spectral subtraction graphs. 
Comparison of single Raman spectra and the subtraction graphs for human and porcine hair (c) and sebum (d) (image taken 
from [138]). 
The staining procedure based on haematoxylin and/or eosin is one of the most common techniques 
used to differentiate between various components in tissue sections. In Figure 10(a) a longitudinally 
cut porcine HF is displayed after undergoing haematoxylin nuclear staining. In this image one can 
clearly differentiate between the follicular epidermis, the dermis, and the hair. The entry duct to the  
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sebaceous gland can be assumed in this specific image (red arrow), but the sebum is undetectable via 
this method.  
Figure 10(b) depicts a longitudinal section of a similar location in a porcine HF, yet unstained. In that 
image, the red square indicates the area which was mapped using Raman in (c), and (d). Raman 
mapping is a method which allows discriminating between various components based on their 
obtained Raman spectra without the need of a previous staining procedure. Thus, it permits 
visualization of the component distribution without the need to treat the sample prior. For this study, 
the spectra of the region of interest were recorded with a step size of 5 µm. After measuring the 
spectral data, a processing step was performed using multi-variant analysis algorithms, in order to 
identify the component distribution. From that data a false-color Raman image was obtained where 
each picture pixel was assigned one color that represents a similar Raman spectrum (see Figure 10(c)). 
During this binary processing method, pixels with a spectrum which represents the follicular epidermis 
are displayed in yellow, dermis in green, sebum in red, and hair in blue. A similar, yet more 
sophisticated procedure was performed for Figure 10(d).  
 
Figure 10: (a) Transmittance-light microscopy pictures of a haematoxylin nuclear stained porcine hair follicle cross-section. 
The red arrow indicates the location of the sebaceous gland. (b) Incident light microscopic picture of an unstained porcine 
follicle cross-section. (c) and (d) Raman map of the area indicated by the red rectangle in (b). The hair is displayed in blue, 
the sebum is depicted in red, whereas epidermal and dermal structures are shown in yellow and green, respectively (image 
taken from [138]). 
 
However, this method includes visualizing intensity differences, plus the possibility of displaying 
multiple components (colors) simultaneously in one pixel. Thus, this type of processing method allows 
for a more specific and detailed depiction of the real component distribution. When taking a closer 
look at Figure 10(c) and Figure 10(d), one can see the advantage of the latter method. For examples, in  
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(d) traces of sebum (shown in red) can be identified on parts of the hair (shown in blue), whereas 
looking only at the binary image in (c), or the light microscopy image in (b), this conclusion cannot be 
drawn. Thus, Raman mapping allows for a more specific and more accurate components distribution 
analysis, which is not feasible by conventional microscopy. Furthermore, this methodology needs no 
labeling or previous staining, and would therefore be ideal for tracking the penetration of drugs with 
and without drug delivery systems into the HF. 
2.1.4.2. Visualization of Cyanoacrylate Skin Surface Biopsies 
For the qualitative and (semi)quantitative analysis of drug penetration into the HF, cyanoacrylate skin 
surface stripping represents the most common analytical technique. It involves removing the hair plus 
the entire follicular cast in a cyanoacrylate biopsy which can later be analyzed and quantified for drug 
content. Nevertheless, an actual quality assurance for the removal of the entire follicular cast cannot be 
given by using conventional light microscopy, as information about only one focal plane is gained via 
this method. This problematic is depicted in Figure 11(a) and (b), where each image displays a light 
microscopic picture acquired from two different focal planes of a porcine cyanoacrylate biopsy. In 
these images the tape strip, which was beforehand placed over the drop of glue in order to remove the 
follicular cast, is turned upside down, and the removed hairs are pointing upwards. However, as only 
one focal plane can be visualized via this method, only parts of the hairs can be analyzed.  
 
Figure 11: (a) and (b) depict light microscopy pictures of a cyanoacrylate skin surface biopsy recorded from two different 
focal planes. (c) Schematic of the basic principle of optical profilometry. (d) Color-coded surface map of the biopsy area 
corresponding to (a) and (b) (image taken from [138]). 
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To get a complete analysis of the entire follicle, a three-dimensional (3-D) analytical approach is 
needed. Optical profilometry presents itself as a useful method for this type of analysis. It represents a 
non-contact interferometric-based method which is used for characterizing surface topography. The 
basic principle which underlies this methodology relies on the effect of chromatic aberration. Using a 
set of hyperchromatic lenses, one obtains very good mapping-point capabilities, along with a high 
chromatic error. Consequently, the white light, which gets focused through this lens assembly, is split 
into its different colors, resulting in the assignment of a specific, yet different, color for each focal 
length. Detection of the light occurs in the confocal pinhole, and, as a result, a topography map is 
generated, as can be seen in Figure 11(c). Applying this method to the above mentioned sample, the 
whole cyanoacrylate biopsy, including the interfollicular epidermis rests plus the entire HF, can be 
visualized (Figure 11(d)). 
Another possible application of this method is to overlay the obtained sample surface topography map 
with Raman spectroscopic information. Thus, after measuring the surface structure, the same sample 
surface can be used to obtain Raman spectra. This is done by diminishing weak signal intensities 
produced by out-of-focus effects. Therefore, this technique makes it possible to apply Raman mapping 
to highly structured specimen like an individual HF obtained from a cyanoacrylate surface biopsy (see 
Figure 12).  
 
Figure 12: (a) Light microscopy picture of an excised hair follicle. (b) Surface topography map of the area indicated by the 
red rectangle in (a). (c) Raman spectra of the individual chemical components in the hair follicle. (d) Raman map displaying 
the component distribution on the excised hair follicle (image taken from [138]). 
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The red square in (a) indicates the area which was measured by optical profilometry and is shown in 
Figure 12(b). For the same area that was mapped in (b), individual Raman spectra were recorded and 
are shown in (c). Overlaying the information obtained from (b) with the spatially resolved information 
gained from the Raman spectra in (c), a 3-D components distribution map of the HF is generated and 
displayed in (d). In this false-color image, the sebum is shown in red, the epidermis in yellow and the 
hair in blue. The information that is acquired from combining these two methods is that the hair shaft 
is completely enclosed by an intact follicular epidermis (inner and outer root sheath) and, thus, the 
whole follicular cast was successfully removed by this cyanoacrylate skin surface stripping method. 
Also visible are traces of sebum along the HF, especially in the bottom areal hinting at a possible 
thinning of the epidermal layers in this region. Overall, this analytical evidence is an important finding 
because it only further corroborates the suitability of this technique (cyanoacrylate skin surface 
stripping) which is (up to date) the only measure for quantifying drug content in the HF. Furthermore, 
the novel combination of confocal Raman microscopy and optical profilometry in this setting proves 
its worthiness in evaluating biological samples, opening the possibility for other similar analytical 
approaches. 
2.1.5. Conclusion 
In this study, confocal Raman microscopy has proven to be an excellent tool for investigating the 
equivalency and suitability of porcine HFs as a model for the evaluation of trans-follicular drug 
delivery. It entails a non-destructive and chemically selective analytical approach, and was shown to 
be very successful in proving the similarities between human and porcine tissue. Based on the 
individual Raman spectra, the four main components (hair, dermis, sebum, and follicular epidermis) 
were effectively identified in both species and found to be equivalent. Moreover, a comparison 
between the common histologic staining procedure and Raman mapping was performed, and 
demonstrated the advantages of the latter. Also, based on the novel combination of confocal Raman 
microscopy and optical profilometry, a 3-D chemically resolved analysis of cyanoacrylate skin surface 
biopsies was achieved, only further proving the suitability of this analytical approach. These results 
corroborate the potential of this methodology in the field of drug delivery, like visualizing the 
penetration behavior of drug delivery systems into the HF or non-invasive depth profiling. 
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Personal contributions to this chapter were as follows: 
 
 Tissue preparation for experiments performed on porcine ear skin 
 Performance, analysis and interpretation of tight junction experiments 
 Performance and analysis of H&E stainings described 
 Sample preparation for transmission electron microscopy experiments 
 Analysis and interpretation of all described results 
 Writing of chapter 
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2.2.1. Abstract 
Follicular penetration has recently been given more attention regarding i) safety concerns of 
nanomaterials which should not enter the skin, and ii) the possibility for nanoparticle-based drug 
delivery. However, potential barriers in the hair follicle (HF) that a substance will encounter upon 
uptake and/or penetration into surrounding tissue remain undetermined up to now. In the interfollicular 
epidermis, functional tight junctions (TJs) have been revealed before. Moreover, several TJ proteins 
have previously been localized in human HF. However, the functionality of these follicular TJ has not 
been investigated this far. Hence, this work investigates and elucidates for the first time a continuous, 
intact TJ barrier from the infundibulum down to the suprabulbar region of mammalian HF. In the 
upper region a double-barrier comprising the stratum corneum and functional TJs was revealed, while 
in lower areas TJs likely act as the only barrier. Moreover, by modulating the permeability using 
EDTA, the dynamic character of this TJ barrier was verified. In the bulb, however, no TJ barrier was 
detected, which proves the importance of free supply for e.g. hormones or nutrients from the dermal 
microenvironment to this hair-forming part. Lastly, transmission electron microscopy revealed that 
model, polymeric nanoparticles (154 nm), which had previously been applied to the skin, were mainly 
found in the upper part of the HF where the previously mentioned double-barrier is present. Few 
particles penetrated deeper; however, they were only found in areas where functional TJs are present. 
Thus, no particles reached areas without an intact TJ barrier. To summarize, follicular regions of high 
accessibility for external substances – here model polymeric nanoparticles – are protected by two 
barriers, while areas with lower accessibility are lined with one functional barrier, TJs. 
2.2.2. Introduction 
The hair follicle (HF) represents a potential entry route for topically applied substances, or 
(exogenous) substances present in the environment [141, 142]. This entry route may be of advantage 
on one hand (e.g. for drug delivery purposes), or of disadvantage concerning the uptake of allergens or 
toxins. In the past few years, there has been an extensive debate around the topic of nanomaterials and 
toxicity, especially concerning the question whether certain particles may or may not penetrate, or 
even permeate, mammalian (in particular human) skin. General agreement has meanwhile been 
reached that nanoparticles (NPs) (both polymer-based or made of metal oxides) > 20 nm do not 
penetrate the stratum corneum (SC), and are therefore unable to reach the viable part of the epidermis, 
let alone the bloodstream [76-78, 143]. Alternatively, several studies have shown that particles in the 
size range of ~100-900 nm accumulate in hair follicles (HFs) to a higher extent than dissolved 
molecules, and even exhibit a size-dependent effect on follicular uptake [83, 84]. Furthermore, it was 
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demonstrated that various nanoparticulate-based delivery systems penetrate into the HF shaft, and can 
serve there as a long-term reservoir for a maximum of 10 days [85-87]. Thus, a possible, yet 
undesired, uptake of toxins needs to be considered. On the other hand, the possibility of targeting the 
HF has also opened novel possibilities for new drug delivery systems, like targeted non-invasive 
delivery of drugs and antigens [90, 92, 144-146]. Thus, for both, understanding the putative risk of 
unwanted uptake of substances, as well as the possibility to deliver drugs via the transfollicular route, 
knowledge about potential barriers present in the HF is crucial. 
As was shortly discussed in Chapter 1, the SC has been identified as the first invasion barrier in 
interfollicular skin [147]. Beyond this structure, located in the stratum granulosum of the viable 
epidermis, are the previously introduced tight junctions (TJs) [148]. These are multi-protein 
complexes in charge of barrier properties. In simple epithelia and endothelia, this barrier function has 
been extensively characterized over the years; however, only recently their role in a stratified 
epithelium (e.g. the skin) has gained increasing interest [31, 57, 148-150]. In 2002, an intact epidermal 
TJ barrier was demonstrated by Furuse et al., along with the revolutionizing discovery of the vital role 
of claudin-1 (Cldn-1) in mice (refer to Section 1.3.4) [58]. Shortly after, this barrier function was also 
revealed to exist in adult human interfollicular epidermis [43, 60, 61]. Using cultured keratinocytes, 
researchers were able to demonstrate that TJ proteins Cldn-1, Cldn-4, occludin (Ocln) and zonula-
occludens protein-1 (ZO-1) contribute to the TJ barrier for ions, as well as small and large molecules 
[123]. Due to their localization underneath the SC, it seems as if TJs serve as a second-line of defense 
for the outside-in passage of substances, especially when the SC barrier is impaired. However, they 
can also actively influence the SC (e.g. abnormally shaped corneocytes, altered ceramide composition 
of SC lipids, altered filaggrin processing, increase in pH of SC, increase in polar lipids and decrease in 
nonpolar lipids), and are therefore likely to be involved in the regulation of SC barrier function[63, 
123, 151]. 
The HF represents an invagination of the skin in which the SC barrier is interrupted, hence,  an intact 
SC is only present in the upper part of the infundibulum [152]. Thus, researchers were wondering 
whether TJs are present in this region of the HF or beyond. In the early 2000s this question was 
answered, as expression and localization of various TJ proteins were revealed in human HFs – 
including lower follicular areas not covered by the SC – as well as in murine skin [30, 153-155]. Also, 
the importance of regular TJ protein expression for normal hair growth was demonstrated in Cldn-1 
knock-out mice, patients with NISCH syndrome (deficiency of Cldn-1 in human), as well as Cldn-6 
over-expressing mice, which all exhibited a peculiar hair phenotype [154, 156, 157]. However, the 
intriguing question whether these follicular TJs actually serve as a barrier, which may or may not 
compensate for the non-existing SC in deeper follicular regions, had not been addressed up to now. 
We therefore took it upon us to investigate TJ barrier function in mammalian HFs. We used porcine 
ear skin, as this model has been accepted as the ‘gold standard’ for follicular uptake studies, and we 
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were interested in comparing the localization of an extracellularly applied exogenous substance – here 
model NPs  -  with the localization of existing barriers in the HF. 
In this study we therefore started by investigating expression and localization of follicular TJs via 
qPCR and immunohistochemical staining, respectively. To be able to compare our results to 
previously published clinical data on humans and preclinical data on mice, we focused our efforts on 
TJ proteins that have previously been localized in the HF of both species before, namely Cldn-1, -3, -
4, Ocln, and ZO-1. Next, barrier function of these TJs was evaluated using the tracer molecule Sulfo-
NHS-LC-Biotin (Biotin-SH), followed by the attempt to modulate this barrier using the Ca
2+
-chelator 
EDTA. Finally, transmission electron microscopy (TEM) was employed to visualize our model NP in 
the HF. 
2.2.3. Materials and Methods 
2.2.3.1. Materials 
Oleic acid-coated primary magnetite particles were kindly provided by the Leibniz Institute for New 
Materials, Saarbruecken.  Poly-D,L-lactide-co-glycolide (Resomer® RG 503 H) was purchased from  
Evonik in Essen, Germany. Uranyl Acetate was obtained from Polysciences Europe GmbH, 
Eppelheim, Germany. For tissue fixation, paraformaldehyde was purchased at VWR International in 
Radnor, PA, USA, and glutaraldehyde at Agar Scientific, Stansted, UK.  HEPES and Eosin Y solution 
0.5% in water were bought at Carl Roth GmbH + Co. KG in Karlsruhe, Germany, and RNAse 
Inhibitor at Fermentas, Waltham, MA, USA. Dulbecco’s Modified Eagle Medium (DMEM), the 
Maxima First Strand cDNA Synthesis Kit, and an O’GeneRulerTM 50-1000 bp DNA Ladder were 
purchased from Thermo Fisher Scientific, Darmstadt, Germany. The RLT buffer and RNeasy Mini Kit 
used for PCR experiments were bought from Qiagen, Venlo, Netherlands. All pig specific primers 
used were ordered from Applied Biosystems in Darmstadt, Germany: 1) Claudin-1 (CLDN1): 
Ss033757089, 2) Claudin-3 (CLDN3): Ss03377787, 3) Claudin-4 (CLDN4): Ss03375006, 4) Occludin 
(OCLN): Ss03377507, 5) ZO-1 (TJP1): Ss03373514, 6) GAPDH (Ss03375435), 7) β-2-microglobulin 
(Ss03391156), 8) β –actin (Ss03376160). EZ-LinkTM-Sulfo-NHS-LC-Biotin (Biotin-SH;557 Da) was 
purchased at Pierce, Rockford, IL, USA. Formaldehyde (Formafix® 4%, buffered) was obtained from 
Formafix Global Technologies,  Duesseldorf, Germany. Mayer’s haematoxyline was provided by 
Medite GmbH, Burgdorf, Germany. All primary antibodies were purchased from Invitrogen Carlsbad, 
CA, USA. The Alexa-488-coupled secondary antibody (F(ab’)2 and Alexa-594-coupled secondary 
antibody (F(ab’)2 were provided by MoBiTec, Goettingen, Germany. For the biotinylation assay, the 
Texas-Red®-conjugated Streptavidin was purchased at Merck Biosciences, Darmstadt, Germany. For 
nuclear staining DAPI was bought at Boehringer Mannheim, Mannheim, Germany and Fluoromount-
G
TM
 at Southern Biotechnology Associates, Birmingham, Ala., USA. Aqueous polyvinyl alcohol, 1% 
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Alcian blue, phosphotungstic acid, dispase, 2-Mercaptoethanol, Hydrocortisone, fetal calf serum, 
penicillin/streptomycin and  ethylenediaminetetraacetic acid (EDTA) were all obtained from Sigma 
Aldrich, St. Louis, MO, USA.  
2.2.3.2. Porcine Ear Skin & Mice  
Fresh pig ears (Yorkshire/German Large White crossbreed; age: 6 months) were donated by a 
slaughterhouse in Schleswig-Holstein, Germany. The ears were excised before brewing, immediately 
brought to the lab, and washed thoroughly. They were carefully examined for skin abrasions prior to 
use, and only ears with immaculate looking skin were selected for experiments. For control 
experiments on the localization of TJ protein Cldn-3 in murine HFs, C57/Bl6 mice (adult) were used.  
2.2.3.3. Isolation of Hair Follicles and Epidermis for qPCR 
Porcine ear skin tissue blocks of 0.3 x 0.5 cm were incubated in a solution consisting of 4.0 mg/ml 
Dispase and 1.0 U/µl RNAse Inhibitor in DMEM at 4°C overnight. Subsequently, whole HFs were 
pinched using a pair of tweezers, washed in phosphate buffered saline (PBS) and stored in 1.0 ml of 
RLT buffer containing 10 µl 2-Mercaptoethanol. As a control, porcine heat-separated epidermis (HSE) 
was used by heating normal skin at 60°C for 90 sec resulting in a distinct separation of the epidermis 
from the dermis [158]. HSE was then washed in PBS and also stored in RLT buffer containing 10 µl 
2-Mercaptoethanol. RNA extraction was done using an RNeasy Mini Kit and tested for purity using 
the NanoDrop 2000C (Wilmington, DE, USA). After successful isolation of RNA, cDNA was 
generated by using a Maxima First Strand cDNA Synthesis Kit. qPCR was performed as previously 
described by Brandner et al. [159] using the parameters recommended by the manufacturer. Resulting 
amplified DNA of qPCR was then separated on a conventional 2% agarose gel using a 50-1000 bp and 
100-1000 bp DNA Ladder as standards. 
2.2.3.4. Biopsy Preparation and Staining Procedures 
Biopsy Preparation 
Biopsies of 8 mm diameter were removed from the inside of the pig ears and placed dermis down in 
DMEM supplemented with hydrocortisone, 2% (v/v) fetal calf serum, and 1% (v/v) 
penicillin/streptomycin. For TJ functionality experiments, 50 µl of 1 mg/ml Biotin-SH in 1 mM CaCl2 
PBS were carefully injected into the dermis and incubated for 1 h at 37°C. For barrier-modulation 
experiments, biopsies were bathed in 8.0 mM EDTA for thirty minutes, prior to injection of the tracer 
molecule Biotin-SH. After this incubation (with and without injected Biotin-SH), biopsies were fixed 
in formaldehyde at 4°C for 12 hours, embedded in paraffin, and 5 µm cross- and longitudinal section 
were cut using a Leica RM2165 Rotary Microtome (Leica Microsystems GmbH, Wetzlar, Germany). 
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Paraffin sections were deparaffinated and rehydrated, after which followed haematoxylin and eosin 
(H&E) staining or immunohistochemical staining.  
Embedding Tissue in Paraffin  
The protocol shown in Table 1 was used to embed the tissue in paraffin. The increasing alcohol 
concentrations first dehydrate the tissue. Xylol is then used to replace the alcohol. The last step, also 
known as the infiltration step, consists of placing the sample into a paraffin bath twice for 2 hours. 
Table 1: Protocol for embedding tissue in paraffin 
Time (hours) 2 2 2 4 4 6 4
Solvent H2O EtOH 70% EtOH 80% EtOH 96% EtOH abs. Xylol Paraffin
 
De-waxing Procedure of Paraffin Sections 
Paraffin sections were dewaxed and hydrated using Xylol (minimum of 2 x 15 min) followed by 
passing the tissue through a series of decreasing alcohol concentrations (EtOH abs, 96%, 80%, 70%) 
and distilled water, immediately after which followed either haematoxylin and eosin (H&E) staining 
or immunohistochemical staining. 
H&E Staining 
Sections were submerged in haematoxylin for 10 min and then left under running water for 10 min 
(bluing step). Next they were rinsed with distilled water, placed into 0.5% Eosin for 40 sec and rinsed 
again. The dehydration process was finalized by passing the tissue through a series of increasing 
alcohol concentrations (70%, 80%, 96%, EtOH abs) followed by submersion into Xylene and 
mounting coverslips using Eukit.  
Immunohistochemical Staining of Porcine and Mouse Paraffin Sections 
After being rehydrated, sections were placed in TEC buffer (0.25% w/v Tris, 0.5% w/v EDTA, 0.32% 
w/v Tri-Sodium Citrate, dihydrate) at 300 W twice for 10 min for epitope de-masking purposes. They 
were washed thoroughly using TBST buffer (6.01% w/v Tris, 8.76% w/v NaCl, 0.5% v/v Tween, 
5.67% v/v 25% HCl; pH 7.6), and incubated with a 0.001% Trypsin solution for 10 min at 37°C. 
Sections were washed again using TBST and soaked in blocking solution (DAKO® Protein Block 
Serum-Free) for 30 minutes at room temperature.  Next, sections were incubated with primary anti-
claudin-1 (1:3000; polyclonal rabbit), anti-claudin-3 (1:100; polyclonal rabbit), anti-claudin-4 (1:60; 
polyclonal rabbit), anti-occludin (1:50; monoclonal mouse), or anti-ZO-1 (1:100; polyclonal rabbit) 
antibody overnight at 4°C. Subsequently, sections were washed three times with TBST and incubated 
  FOLLICULAR TIGHT JUNCTIONS AS A BIOLOGICAL BARRIER 
- 42 - 
 
with Alexa-488-coupled secondary antibody (F(ab’)2 anti-mouse/rabbit (depending on primary; 
1:500), or Alexa-594-coupled secondary antibody (F(ab’)2, anti-mouse/rabbit, 1:500, or a mixture of 
the above mentioned secondary antibodies and Texas-Red®-conjugated Streptavidin for 30 min. For 
nuclear staining, DAPI was used. At last, slides were washed twice with PBS and distilled water and 
coverslips were mounted using Fluoromount-G
TM
. 
Light and Immunofluorescence Microscopy for H&E and Immunohistochemical 
Stainings 
Immunohistochemical stainings of 5 µm sections were examined using a Zeiss axiophot II 
fluorescence microscope (Zeiss, Göttingen, Germany) with the software Openlab 5.0.2 (Improvision, 
Coventry, UK). H&E stainings were examined using a Leica DM LS microscope (Leica Microsystems 
GmbH, Wetzlar, Germany). For each analysis, at least 5 sections per skin sample were evaluated. 
2.2.3.5. Model PLGA-Nanoparticle Preparation and Characterization 
The magnetite-loaded PLGA-NP used for the TEM experiments were prepared via a modified single 
emulsion-evaporation method. In brief, oleic acid-coated primary magnetite particles, kindly provided 
by the Leibniz Institute for New Materials, Saarbruecken [160, 161] were dispersed in chloroform 
containing poly-D,L-lactide-co-glycolide (PLGA, Resomer® RG 503 H). After adding aqueous 
polyvinyl alcohol, particles were homogenized using sonication. Water was added to expand the 
volume, and the dispersion was left overnight under moderate stirring for the organic solvent to 
evaporate. To assure that only particles loaded with iron oxide were used for the experiments, 
magnetic separation was performed and agglomerates were removed by filtration. Size and 
polydispersity of the particles were determined by means of dynamic light scattering analysis using a 
Zetasizer Nanoseries (Malvern Instruments, Worcestershire, UK).  
2.2.3.6. Transmission Electron Microscopy 
Visualization of pure NP was done by negative staining electron microscopy [162]. Briefly, NP were 
adsorbed onto hydrophilized (with 1% Alcian blue) sample supports (pioloform-coated and carbon 
reinforced grids) by adding 10 µl of the NP suspension, and incubating for 10 min at room 
temperature. After three washing steps using aqua dest., samples were stained using heavy metal stains 
phosphotungstic acid and uranyl acetate, and left to air dry. 
Visualization of NP in the HF was performed by ultrathin section TEM as previously described [162]. 
Beforehand, 50 µl of 2.12 mg/ml particles suspended in water were applied onto a predetermined and 
cleansed area of porcine ear skin. A three min massage was performed using a gloved forefinger, and, 
subsequently, particles were incubated on tissue for 1 h. Next, 4 mm biopsies were taken and placed 
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into 1% paraformaldehyde and 2.5% glutaraldehyde in 0.05 M HEPES buffer at room temperature for 
fixation. Biopsies were cut using a scalpel into slices of approximately 1 mm thickness.  
Sample dehydration and embedding was done according to the rapid embedding procedure described 
in reference [162], with slightly changed incubation times on ice: ethanol 50, 70, 100, 100% for 10 
min each; mixtures of resin (LR White) and ethanol 1:1, or pure resin for 10 min each; after an 
additional step in pure resin for 15 min, samples were embedded in fresh resin which contained 5 µl of 
accelerator per ml resin. Complete polymerization was achieved after 90 min on ice. To remove 
remaining unpolymerized resin, samples were placed at 60°C for a few hours. Thin sectioning was 
performed using an ultramicrotome (UC7, Leica, Leica Microsystems GmbH, Wetzlar, Germany), and 
ultrathin sections were placed on pioloform-coated single slot grids. No section staining was done. 
Semi-thin sections were collected on glass slides, stained with toluidine blue and analysed using a 
phase-contrast light microscope (Axiophot, Zeiss, Göttingen, Germany) equipped with a digital CCD 
camera (ColorviewII, Olympus Soft Imaging Solutions (OSIS) GmbH, Muenster, Germany). 
TEM was done on a Tecnai12 Biotwin (FEI Corp., Hillsboro, Oregon, USA) microscope run at 120 
kV acceleration voltage. Images were taken using a digital CCD camera (Megaview III, OSIS GMbH, 
Muenster, Germany) and a resolution of 1376x1024 pixel. 
2.2.4. Results and Discussion 
For all results discussed in this paper, only terminal anagen HFs were considered. This phase was 
distinguished from the other growing phases based on the complete structure of the HF composed of 
an infundibulum, an isthmus, a central region, the suprabulbar zone and the hair bulb [14]. For a 
comprehensive overview of the structure of the HF see Figure 2. 
2.2.4.1. Expression of TJ Proteins in Porcine Hair Follicles and 
Epidermis 
Presence and distribution of TJ proteins have to date only been shown in human and mouse, but not 
porcine HFs. Therefore, the first objective was to look at the expression of the TJ proteins of interest 
in porcine tissue and compare them to previously published human data [30]. Using qPCR, mRNA 
from isolated porcine HFs encoding Ocln, ZO-1, as well as Cldn-1, -3, and -4 were identified and 
analyzed. Amplified DNA obtained was separated and visualized using gel electrophoresis (see Figure 
13a-b).  
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Figure 13: Expression of various TJ proteins in porcine hair follicles and epidermis. a) 2% agarose gel analysis of amplified 
DNA encoding GAPDH (lane G) as a control, ZO-1 (lane Z), Cldn-1 (lane 1), Ocln (lane O), and Cldn-4 (lane 4) in pinched 
porcine hair follicles. b) 2% agarose gel analysis of amplified DNA encoding GAPDH (lane R) as a control and Cldn-3 (lane 
3) in pinched porcine hair follicles. Lanes R = 50-1000 bp ladder, Lane NC1 and NC2 = negative controls. n=3. c) Cycle 
threshold (Ct) values for genes of interest (CLDN1, CLDN4, OCLN, TJP1 (ZO-1)), as well as three separate housekeeping 
genes (GAPDH, ß-2-microtubulin, ß-actin) in porcine hair follicles compared to porcine epidermis; n≥3. Note the higher 
differences of Ct values for housekeeping genes between hair follicle and epidermis than for TJ proteins. 
 
Normal expression of Cldn-1, -4, Ocln, and ZO-1 in porcine HFs could be detected and was in 
accordance with what had previously been shown in human HFs [30]. For Cldn-3, which had not been 
investigated before in human skin, only a weak signal was observed (Figure 13b). The results obtained 
were then compared to the expression levels in porcine epidermis, in order to determine whether the 
genes of interest are expressed alike in both structures. Interestingly enough, when using the same 
amounts of mRNA, our genes of interest, especially the ones encoding Cldn-1, were expressed more 
alike (determined via cycle threshold (Ct) values) in HFs and epidermis) than all three housekeeping 
genes used, hinting at the possibility of using CLDN1 (gene) as a more relevant housekeeping gene to 
compare HF and interfollicular skin (Figure 13c). The Ct value mentioned here is generally defined as 
the number of cycles required to obtain a fluorescence signal above the threshold (i.e. above 
background noise), and this number is inversely proportional to the amount of target nucleic acid in 
the sample [163]. When comparing our data to previously published data on TJ protein distribution in 
human HF [30], our Ct values were in accordance to what had been shown via immunofluorescence: 
Cldn-1 being expressed most and Ocln the least (Cldn-3 had not been investigated before). Overall, 
these findings gave a basis to believe that, as expression in both structures was similar quantitatively, 
function of these structures with regard to barrier properties may be similar, too. Hence TJs in the HF 
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may exert a significant barrier function as has been demonstrated for TJs in the interfollicular 
epidermis before [43]. 
2.2.4.2. Localization of TJ Proteins in Porcine Hair Follicles: a 
Comparison to Human Tissue 
The next step was to investigate the distribution of the TJ proteins of interest and compare those to 
previously published data on human. Thus, the localization pattern for the five mentioned proteins 
(Cldn-1,-3,-4, Ocln, ZO-1) among porcine follicular epithelia was identified using 
immunohistochemistry (see Figure 14). For clarification regarding the anatomy of the HF during this 
section, the reader is kindly asked to refer to Figure 2.  
Claudin 1 & Claudin 4 
In porcine HF, Cldn-1 was distributed throughout all viable layers of the epidermis and the outer root 
sheath (ORS) of the infundibulum and isthmus (Figure 14a-b). In the upper central region, Cldn-1 
staining was intense in the central cell layer (CCL) and companion cell layer (CL), but none was 
observed in the basal cell layer. In the lower central region, Cldn-1 was limited to the outermost layer 
of the CCL and the CL, while in the suprabulbar/bulbar zone staining was only positive in the CL 
(Figure 14c-d). Matrix cells in the bulb, as well as cortex and cuticle of the hair shaft, were faintly 
positive (see Figure 14c-d). In the inner root sheath (IRS), which consists of Henle’s layer (He), 
Huxley’s layer and the cuticle, all layers revealed strong staining, except for the fully differentiated 
and highly keratinized Henle cells (He*). These cells and their characteristic keratinization 
development have previously been described in detail by various hair specialists like Langbein or 
Alibardi and Bernd [24, 155]. For a detailed review the reader is kindly asked to refer to those 
references.  
For Cldn-4, a typical staining of the stratum granulosum and upper layers of stratum spinosum was 
observed in the epidermis and infundibulum of the HF (Figure 14e). In the ORS of isthmus and upper 
central region, Cldn-4 was found in the CCL and CL, while in the lower central and suprabulbar 
region the staining was confined to only the CL (Figure 14f-g). As for distribution within the IRS of 
the HF, Cldn-4 staining was intense in all three compartments, yet strongest for Henle’s layer, except 
again for He* (Figure 14h). Matrix cells and cuticle of the hair shaft in the bulbar region showed 
intense staining, except the ones directly enclosing the dermal papillae.  
Distribution of Cldn-1 and Cldn-4 was similar to what was shown in human HFs in the upper parts, 
while in the central and suprabulbar ORS layers, as well as in the hair shaft region, small 
contradictions were observed [30]. The previous results in human HFs exhibited a broader staining for 
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Cldn-1 and Cldn-4 in the ORS. However, after restaining human scalp tissue under the same 
conditions, the same distribution as had been observed in porcine HFs was also seen in human skin. It 
is very likely that these differences in the staining distribution can be explained by different fixation 
processes
4
 resulting in different antigen accessibility. Also, a new batch of antibodies, which may 
contain slightly different concentrations of antibody, could be a possible explanation. 
ZO-1 
An intense staining of ZO-1 was found in the stratum granulosum and the upper layers of stratum 
spinosum in the interfollicular epidermis and infundibulum (Figure 14i). In the isthmus and central 
region of porcine HF, ZO-1 was strongly positive in all cell layers of the ORS (Figure 14j-k). The 
suprabulbar region revealed a more intense staining of the CL than surrounding cell layers, yet it was 
visible throughout the entire ORS of the bulbar and suprabulbar region. Within the bulb the IRS 
exhibited strong staining of ZO-1, with the undifferentiated cells of Henle’s layer being the most 
intense. In the suprabulbar region the IRS remained positive, but staining intensity in Henle´s layer 
decreased with He* being completely negative (Figure 14k-l). The matrix cells, lower cortex and 
cuticle of hair shaft showed an intense ZO-1 staining, whereas the upper cortex displayed only 
moderate staining (Figure 14k-l). The staining pattern was overall similar to that found in human HFs 
[30]. 
Occludin (Ocln) 
In the interfollicular epidermis and infundibulum, Ocln was restricted to the stratum granulosum 
(Figure 14m). This narrow distribution continued on through the isthmus and central region, as only 
the CL of the ORS stained positive (Figure 14n-o). The suprabulbar region still exhibited staining in 
the CL, but no presence of Ocln in the ORS of the bulb was seen (Figure 14p). Among the IRS, 
Henle’s layer was positive for Ocln in the bulbar, suprabulbar, and lower central region. No staining at 
all was observed in the matrix cells, but some was seen in the more differentiated matrix cells and 
medulla (Figure 14o). The staining pattern was similar to human HFs [30] except for a slightly broader 
localization of Ocln in the ORS of the upper parts of human HFs. Again, the difference in fixation may 
be an explanation for this. 
                                                     
4
 In 2003, sections were prepared via cryo fixation while for this study formalin fixation and paraffin embedding 
was done for better quality sections 
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Figure 14: Localization of TJ proteins in adult porcine hair follicles. Immunofluorescence-based localization of Cldn-1 (red; 
a-d), Cldn-4 (green; e-h), ZO-1 (red; i-l), Ocln (green; m-p), and co-localization of Cldn-1 & Ocln (red & green;q-t) in 
infundibulum (a,e,i,m,q), isthmus/upper central region (b,f,j,n,r), lower central/suprabulbar region (c,g,k,o,s), and bulb 
(d,h,l,p,t) of HFs. Blue: nuclei; yellow: co-localization of green and red. CCL = central cell layer of the ORS, CL = 
companion cell layer of ORS, DP = dermal papilla, He = Henle’s layer of IRS, He* = differentiated cells of Henle’s layer of 
IRS, IRS = inner root sheath, MC = matrix cells, ORS = outer root sheath, ++ = regions of co-localization of all TJ proteins. 
Scalebar = 80 µm. 
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Claudin 3 
Because Cldn-3 was shown before at cell-cell membranes in murine HFs [48], and because it had 
given a weak signal via qPCR (see Figure 13), it was also examined here. However, 
immunolocalization revealed that Cldn-3 was only found very weakly and mainly intracellularly in 
porcine epidermis and HFs (Figure 15a,b) , even though it was positive in porcine sweat glands and 
murine HFs (Figure 15b,c). These results were, again, in accordance with human data, as staining of 
human HFs had also given an only very weak, mainly intracellular staining (unpublished data). This 
was an interesting finding, as it hints at differences between porcine/human and murine HFs, with 
Cldn-3 not playing a part in barrier function. 
 
Figure 15: Localization of Cldn-3 in pig (a,b,d,e) vs. Cldn-3 in mouse skin (c,f). Cldn-3 immunolocalization (green) in 
porcine epidermis (a), porcine hair follicle (b) and mouse hair follicle. (d-f) represent corresponding phase contrast pictures. 
Note that Cldn-3 is found only weakly and mainly intracellular in porcine epidermis and hair follicles while it is clearly 
positive at cell-cell borders in murine hair follicles (companion cell layer of the ORS (arrows in c) and faintly in the IRS, as 
well as sweat glands in porcine skin (arrowhead in (b)). Scalebars = 50 µm. 
Co-localization of TJ proteins 
As it is likely that functional TJs are only found in areas where TJ proteins co-localize (for review see 
[58, 148, 164]), we took a closer look to identify those areas of co-localization throughout porcine 
HFs. Figure 14q-t and Figure 16 are examples which display this co-localization nicely. In the past, 
functional epidermal TJs in healthy skin have mainly been detected at areas where Ocln is present in 
the stratum granulosum [43, 58, 164, 165]. And although a lack of Ocln does not necessarily influence 
barrier function of TJs [37, 166], this protein is the most restricted one resulting in its frequent use as a 
surrogate marker for TJ detection in skin, as it mostly co-localizes with tracer stops at TJs in the 
epidermis. 
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In Figure 14q-t and Figure 16, Cldn-1 is shown in red and Ocln in green, resulting in a yellow/orange 
appearance at points of co-localization. In the infundibulum of porcine HFs, a co-localization of all 
four TJ proteins was detected at the stratum granulosum (Figure 14a,e,i,m,q) and it continued down 
the CL of the ORS from the isthmus to the suprabulbar region (Figure 14b-d,f-h,j-l,n-p,r-t, Figure 16). 
In the lower central region, suprabulbar region, and bulb the proteins were co-expressed in Huxley’s 
layer of the IRS hinting at a possible barrier at those sites (Figure 14c-d, g-h, k-l, o-p, s-t).  
 
Figure 16: Co-localization of Cldn-1 and Ocln in companion cell layer of ORS in isthmus region of porcine hair follicle. (a) 
shows Cldn-1 in red, (b) Ocln in green, (c) DAPI in blue, and (d) represents an overlay of all three stainings. Scalebar = 
20 µm. 
 
Thus, it seems as if throughout the entire HF, from the infundibulum down to the suprabulbar region, a 
putative barrier may exists which may be involved in regulating invasion of exogenous substances 
from the outside, as well as loss of water and nutrients from the inside. Overall, (co)-localization of all 
of the investigated TJ proteins was similar between pig and human, making the porcine HF a good tool 
to investigate TJ barrier function in HFs. 
2.2.4.3. TJs as a Biological Barrier in Hair Follicles 
In healthy human skin and newborn mice, the polar, biotin-labeled extracellular tracer molecule Sulfo-
NHS-LC-Biotin (557 Da, Biotin-SH) has been used to investigate TJ functionality [43, 58, 165, 167]. 
In newborn mice and healthy human skin, this tracer molecule was stopped, when applied from the 
dermis side, at the most apical sites of TJ protein co-localization. Interestingly, changing the site of co-
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localization (e.g. in psoriasis vulgaris [168, 169]), or applying the TJ modulator cCPE [151], resulted 
in changing the localization of the Biotin-SH stop or complete abolishment of the tracer stop, 
respectively. Figure 17 shows reproducibility of these results in healthy porcine tissue.  
 
Figure 17: Biotin-SH gets halted at Cldn-4 positive sites in stratum granulosum of porcine epidermis. (a) Biotin-SH staining 
in red, (b) Cldn-4 staining in green, (c) DAPI in blue, and (d) represents an overlay of (a-c). Arrowheads denote Cldn-4-
positive sites in granular cell layer where Biotin-SH stops. Scalebar = 30 µm.  
 
Similar to human skin [43], the tracer molecule penetrates towards the skin surface and gets halted at 
the most apical point of TJ protein co-localization, e.g. granular cell layer. Next, this well-established 
and reliable assay was used to test functionality of follicular TJs in porcine skin. Thus, longitudinal-
sections (Figure 18) and cross-sections (Figure 19) of porcine HFs, which had previously been 
injected with the tracer Biotin-SH and later stained for TJ proteins, were thoroughly investigated. 
In the infundibulum, a functional barrier was to be expected in the stratum granulosum, similar to 
what was observed in the epidermis (Figure 17). As depicted in Figure 18a-c and Figure 19a-b, a 
tracer stop was indeed seen in this cell layer. In the longitudinal-, as well as the cross-sections, Biotin-
SH spreads from the dermis into the viable part of the epidermis; yet it is not able to penetrate past the 
outermost site of the Cldn-1 and Cldn-4 staining, the apical part of the stratum granulosum. Of note, 
this specific localization is also the site where the narrow Ocln staining is present (Figure 18d)). 
Similarly, in the isthmus and upper central region of porcine HFs, a TJ barrier was observed in the CL 
of the ORS (Figure 19d-i)).The lower central and upper suprabulbar region give rise to two individual 
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barrier sites in two distinct compartments of the HF, one in the CL of the ORS (Figure 18f-g) 
arrowhead pointing to the left & Figure 19j-k), and one in Huxley’s layer of the IRS (Figure 18f-g) 
arrowhead pointing to the right & Figure 19j-k)). The tracer spreads from the dermis into the ORS of 
the HF to the point of co-localization of at least four (Cldn-1, Cldn-4, Ocln, ZO-1) TJ proteins in the 
CL. Simultaneously, the tracer molecule permeates from the bulb (see below) upwards via the matrix 
cells, hair cortex, and cuticle into the IRS up to Huxley’s layer where it is stopped. 
 
Figure 18: Barrier function of follicular TJs displayed in longitudinal-sections. Immunohistochemical stainings of Biotin-SH 
(red), Cldn-1 (green), Ocln (white), and DAPI (blue, nuclei). (a-d) infundibular region, (e-k) lower central/suprabulbar 
region, and (l-o) bulb. White boxes in a, e and l represent areas magnified in b-c, f-g, i-j, and m-n, respectively. Arrowheads 
highlight points where Biotin-SH is stopped (b-h) (c-d, g-h); He = Henle’s layer, He* = differentiated cells of Henle’s layer, 
DP = dermal papilla. Scalebars = 50 µm 
This is in accordance with all data discussed before, as exactly in these layers, the CL and Huxley´s 
layer, a co-localization of various TJ proteins occurs. Of note, tracer flux into the fully differentiated 
and keratinized cells of Henle’s layer (He*) in the IRS [24, 155] is blocked from two sides: the most 
proximal layer of the ORS (CL) and the most distal layer of the IRS (Huxley). For that reason, the He* 
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cells appear black in Figure 18f & Figure 19g-f. For a simplified depiction of this situation, please 
refer to Figure 20a.  
 
Figure 19:  5 µm cross sections of porcine HFs from infundibulum (A-C), upper central region (D-F), lower central region 
(G-I), suprabulbar region (J-L) and bulb (M-O) demonstrating intact barrier properties from the infundibulum down to the 
suprabulbar region. The bulb was freely permeated. Sections on the left represent Cldn-1 (green), Biotin-SH (red) and DAPI 
(blue). Middle sections show Cldn-4 (green), Biotin-SH (red) and DAPI (blue). Sections on the right are H&E stainings of 
representative regions shown to the left. ** highlight examples of intact barrier, °° denote no barrier. SG=stratum 
granulosum, SC=stratum corneum, M=Medulla, ORS=outer root sheath, He=Henle’s layer of IRS, Hu=Huxley’s layer of 
IRS, C=cortex, Cu=cuticle, DP=dermal papillae. Scalebar = 20 µm. 
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Only about 70 µm further down the hair shaft, in the lower suprabulbar region magnified in Figure 
18i-j, these two barrier sites seem to not be established yet. Here, Biotin-SH permeates from two sides: 
1) via the bulb into the hair shaft to the IRS, and 2) from the dermis into the ORS up to the point of TJ 
co-localization in the CL of the ORS. In contrast to above, however, Henle’s layer gets freely 
permeated in this lower region. A putative explanation for this scenario could be that while two points 
of co-localization were observed in the upper suprabulbar region (in the IRS & ORS; see two X’s in 
Figure 20a), only one monolayer is subject to co-expression in the lower part (located in the CL of the 
ORS; single X in Figure 20b). Thus, in the latter situation the tracer molecule permeates from two 
sides, via the IRS and ORS, and only gets halted at one ‘fine line’, making the stop not visible to the 
normal eye. However, this is only a hypothetical explanation, and, of course, another one could be that 
simply no TJ barrier is present in this region. 
 
Figure 20: Cartoon depicting permeability of Biotin-SH in untreated porcine HFs at TJ borders in upper suprabulbar region 
(a) and lower suprabulbar region (b). Red arrows represent Biotin-SH, black lines represent functional TJs, and yellow X’s 
display the area where Biotin-SH gets blocked (a) or hypothetically may be get blocked (b).   
 
The bulb of the HF is not protected by a TJ barrier at all. Biotin-SH permeates from the dermis into 
the bulb, most likely via the dermal papilla and the matrix cells, which do not contain neither Ocln, 
nor Cldn-1 (Figure 18l-o & Figure 19m-n). This confirms previous work published on cell-cell 
communication in rat HFs in which the tracer dye Lucifer yellow was applied to demonstrate 
spreading of the dye after injection into the matrix region of rat HFs [170].  
Noteworthy is that the manual application of Biotin-SH to the epidermis (i.e. from the outside) was 
also performed in order to mimic outside-in barrier conditions in the HF. This was, however, 
unsuccessful. The tracer molecule did not penetrate past the first layer of corneocytes in the SC 
(Figure 21a), and not at all into the HF (even after massaging the skin post-administration) (Figure 
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21b). This is in accordance with what has been reported before about solutions (in contrast to NPs) not 
penetrating into HFs [83]. 
 
Figure 21: Intact barrier function of the “limiting barrier”, the stratum corneum, to Biotin-SH in porcine epidermis (a) and 
infundibulum of hair follicle (b). (a, b) Overlay of Biotin-SH (red), Cldn-1 (green), DAPI (blue) and a transmitted light 
image. Scalebars = 30 µm. 
 
Summarizing this data, barrier-forming TJs exist in the ORS from the infundibulum down to the upper 
suprabulbar region of the HF. In the infundibulum this TJ barrier is – similar to the epidermis – an 
addition to the SC, but in lower areas it is likely the only barrier. In the bulb, however, no obvious 
barrier hinting at functional TJs was detected, and the tracer molecule was able to permeate freely
5
. 
Therefore, TJs seem to compartmentalize the HF i) into areas that are freely accessible from the 
dermal microenvironment, i.e. the hair-forming area of the bulb and the ORS (containing the bulge 
area), which may be important for the supply and control of nutrients and signaling molecules; and ii) 
into areas that are restricted from the extracellular supply by the dermal microenvironment, i.e. the 
upper areas of the IRS, especially the He*. This may be important to reduce and/or prevent the loss of 
hormones, nutrients, or other solutes via the HF, plus to possibly keep exogenous substances from 
translocating into the outer layers of the HF and/or entering the bloodstream. 
2.2.4.4. Modulation of Tight Junction Barrier Function using EDTA 
After barrier properties of follicular TJs had successfully been demonstrated, EDTA was used to test 
whether this barrier can be modulated, as is displayed in Figure 22.  
                                                     
5 Of note, even though the tracer was applied only from the dermal side (inside-out barrier function), we can 
conclude that TJs also form an outside-in barrier at the same sites, because the permeation of solutes through TJs 
is bidirectional and only dependent on the gradient of the substances. Therefore, when a barrier for permeation 
exists, it exists in both directions. Because TJs form a functional inside-out barrier in the HF, especially in areas 
where NP were found, we can conclude that they also form a functional outside-in barrier in these areas [170].  
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Figure 22: Direct comparison between intact barrier in suprabulbar region of untreated porcine HF (a) and impaired barrier 
in with 8.0 mM EDTA treated tissue (b). (c) represents an intensity curve for tracer molecule Biotin-SH in images for 
selected area denoted by two white lines in (a) and (b), respectively. Blue boxes in (c) highlight region of interest 1 (ROI 1) 
of intact barrier to Sulfo-NHS-LC-Biotin in (a) indicated by intensity curve dropping down to the baseline vs. impaired 
barrier in (b) indicated by a rise in intensity in ROI 2 of ~30%. He*=differentiated cells of Henle’s layer, ROI=region of 
interest. Scalebar = 15 µm. 
 
EDTA is a well-known Ca
2+
-chelator and has been shown to impair TJ functionality in cells, resulting 
in increased permeability [171, 172]. Thus, untreated and EDTA-treated samples were analyzed 
simultaneously. For samples which had not been treated using EDTA, a clear stop of Biotin-SH was 
seen at Huxley’s layer of the IRS, as well as at the CL of the ORS, leaving He* black (Figure 22a). In 
the EDTA-treated samples, however, the tracer permeated this layer of fully differentiated cells, 
making He* appear red (Figure 22b). To further examine this matter, an intensity analysis (Figure 22c) 
of Biotin-SH was performed at the regions of interest (ROI) highlighted in Fig. 24a-b. While the 
intensity curve at He* is close to the baseline in the untreated sample (ROI 1), it is significantly higher 
(about 30%) for the EDTA-treated sample (ROI 2), only further confirming previous results. For the 
sake of correctness, it has to be noted that EDTA does not only address TJs. By chelating Ca
2+
 it also 
disturbs adherens junctions. Nonetheless, adherens junctions are no barrier-forming junctions, hence 
the observed effect on barrier function is most likely TJ-mediated. 
2.2.4.5. Visualization of PLGA-based Nanoparticles in Hair Follicles  
Based on the newly found data discussed above, the following question aroused: can the organization 
of the different barriers in the HF [two barriers in the infundibular region (SC and TJs), one barrier in 
the isthmus/central/suprabasal region (TJs), and a complete lack of a barrier in the bulb] be interpreted 
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as the biological answer to the varying accessibility of exogenous substances to the hair shaft? To 
investigate this further, model NPs were applied to porcine ear skin, and the distribution of these 
particles within the hair shaft was compared with the distribution of these various barriers in different 
follicular regions.  
Since follicular penetration of NPs with respect to drug delivery has also become a field of surging 
interest over the last decade, polymer-based NPs were used. Until now, only indirect detection of NPs 
based on fluorescence microscopy had been discussed in literature [77, 83, 85, 145]. However, for this 
study we used PLGA-based NP (mean diameter = 154 nm; polydispersity index = 0.02; see Figure 23) 
loaded with primary magnetite particles (10 nm) in order to visualize, and simultaneously evaluate, the 
uptake, intactness, as well as potential translocation of individual particles in the HF.  
In Figure 23a) the NP depicted are completely embedded in a thin film of the heavy metal stain 
(phosphotungstic acid), which makes the background appear dark. The particles are spherical in shape, 
and homogeneous in size. The bright low-scattering PLGA matrix is clearly visible with dense 
magnetite particles embedded within.  
 
 
Figure 23 Negative staining transmission electron microscopy of magnetite-loaded PLGA nanoparticles. (a) NP embedded in 
heavy metal stain (phosphotungstic acid) (b) Nanoparticles from the same sample preparation as in (a), but without a staining 
film resulting in dehydrated particles. Scalebars = 200 nm. 
 
In Figure 23b) the same NPs are shown, however, no staining was performed in order to mimic the 
situation in the non-stained biological tissue. Here, the PLGA matrix of the NPs has collapsed during 
the final drying step, leaving only magnetite particle clusters visible. This information was important 
to obtain, as such a drying effect is to be expected during the final processing steps of the tissue 
samples which contain these NPs. Dehydration, as well as plastic embedding, may be a cause of this 
effect. Nonetheless, the preserved clusters of the magnetite particles give an indication on whether the 
particles stay intact or not upon penetration. 
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As has been proposed in literature before, applying the NP suspension onto porcine ear skin, together 
with a slight massage, resulted in the highest accumulation of NP in (or on) the SC of the 
infundibulum of the HF (Figure 24ai-av) [76, 83]. Of note, in all magnifications, the homogeneously-
sized, spherically-shaped clusters of the magnetite particles are visible; hence particles stay intact upon 
penetration.   
 
Figure 24: Localization of PLGA-NP in infundibulum of HF(a) and central region of HF(b). (ai) Light microscopy image of 
the infundibular region of the HF. Inset: TEM image of a corresponding ultrathin section. Square: stratum corneum 
magnified in (aii); circle: infundibular region magnified in (aiii-av); each image represents a magnification of the previous 
one; Scalebars = 200 µm, 1 µm, 10 µm, 2 µm, and 200 nm for a-e, respectively. (bi) Light microscopy image of a semi-thin 
section depicting overview of a diagonally cut HF in upper central region; (bii) corresponding ultrathin section of (bi); (bii-
biv) each represent magnification of previous one. Inset in (biv) represents final magnification. Scalebars = 500 µm, 100 µm, 
2 µm, and 300 nm, for bi-biv, respectively. h=hair, ORS=outer root sheath, *=sebum. 
 
Figure 24bi-iv displays the central region of a HF cut diagonally. Here, individual intact particles (see 
inset in Figure 24biv for final magnification) did penetrate into the hair shaft, reaching parts of the HF 
about 500 µm away from the skin surface. These individual particles, embedded in the epithelium, 
also demonstrated preservation of the PLGA matrix i.e. intactness of the particles upon penetration, 
revealed by the expected side of the clusters of magnetite particles (see biv including inset). As was 
expected, the particles appeared in a dried and collapsed state, which is an artifact resulting from the 
sample preparation process, as was discussed before (Figure 23b). In this study, the particles were 
mainly observed in the cuticle/Huxley layer of the IRS (Figure 24bii-iv) but a translocation of these 
individual particles into the ORS, let alone the dermis, was not observed here. 
Thus, the detection of majority of the particles in the infundibulum, which was previously shown to be 
protected by the double-barrier consisting of the SC and TJs, is only reasonable. Few particles were 
seen in deeper areas of the hair shaft, yet it seems as if they were not able to penetrate past the TJ 
barrier in those regions. No particles at all were observed in parts of the HF which is not protected by 
any barrier (i.e. the bulb). 
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2.2.5. Conclusion 
This work shows for the first time the existence of a continuous TJ barrier in the ORS of mammalian 
HF, ranging from the infundibulum down to the suprabulbar region. While in the lower follicular 
regions they are likely the only barrier, they seem to act as a second line of defense, next to the SC, in 
the infundibulum of the HF. The application of model NP to the skin and subsequent analysis using 
TEM demonstrated that majority of the particles were located in the upper follicular region protected 
by this double-barrier (SC and TJs). Fewer particles were located in parts of the HF where TJs seem to 
act as the only barrier. Thus, we hypothesize, that the two follicular barriers, the SC and TJs are 
organized according to the principle of risk stratification: areas with a high accessibility are protected 
by two barriers, whereas in areas with lower accessibility, only one barrier is present. Moreover, 
besides the continuous barrier in the ORS, another TJ barrier was detected in Huxley’s layer of the 
IRS in the suprabulbar region; the bulb, however, seemed to be completely permeable. Therefore, as a 
result of these different TJ barriers in various regions of the HF, it can be concluded that a 
compartmentalization of the HF occurs that divides it into areas accessible and non-accessible from 
the dermal microenvironment. This argues for a potential role of these barriers, not only concerning 
the invasion of exogenous substances, but also for the loss of solutes, and likely also for HF biology. 
Finally, expression and co-localization of the investigated TJ proteins in porcine HFs were shown to 
be equivalent to human skin, indicating suitability of this model regarding TJ barrier experiments, and 
thereby arguing for a transferability of our results to human HFs. 
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2.3.1. Abstract 
Glucocorticoids are essential for the treatment of many dermatological conditions, ranging from 
inflammatory-based hair disorders to eczema or psoriasis. However, these drugs are known to cause 
severe systemic as well as local adverse effects even when only applied topically. Optimizing the 
balance between the release of drug, interfollicular permeation, and follicular uptake may allow 
minimizing these adverse effects given that one succeeds in targeting a sustained release formulation 
to the hair follicle. To test this hypothesis, three different polymeric nanocarriers (nanospheres, 
nanocapsules, lipid-core nanocapsules) encapsulating the potent glucocorticoid Clobetasol propionate 
(CP) were prepared, all providing a sustained release of drug as was demonstrated by separate in vitro 
experiments. They were each formulated as a suspension and hydrogel and (partially) labeled with 
Rhodamin B for quantification purposes. Follicular uptake was evaluated using the Differential 
Stripping method and nanocapsules in suspension were found to achieve the best recovery (4%) after 
application of a massage. In contrast, only minimal amounts of CP were detected in the hair follicle 
when applied as free drug in solution or hydrogel, regardless of the use of massage. Skin permeation 
experiments using heat-separated human epidermis mounted in Franz Diffusion cells revealed similar 
decreased transdermal permeability for all three nanocarriers when compared to free drug. 
Summarizing these results, nanocapsules in suspension and applied using massage were shown to be a 
good candidate for maximizing follicular targeting, minimizing drug permeation, and releasing the 
drug in a steady and continuous manner. We conclude that such nanoparticle-based formulations offer 
a viable strategy for achieving more efficient glucocorticoid delivery to the hair follicle, while 
potentially decreasing adverse effects by releasing the drug in a controlled manner and decreasing 
interfollicular permeation simultaneously.  
2.3.2. Introduction 
Glucocorticosteroids are considered to be first-line agents for many diseases in the field of 
dermatology [173]. Their wide range of therapy includes high-prevalence skin disorders like eczema, 
atopic dermatitis, or psoriasis to diseases in which the inflamed or diseased hair follicle (HF) serves as 
the main target, e.g. lichen planopilaris (LPP), alopecia areata (AA), or frontal, fibrosing alopecia 
(FFA) [95, 174-179]. As has been discussed in Chapter 1, the skin is very effective in limiting 
xenobiotics access to the body. Nonetheless, some substances can still passively diffuse through the 
stratum corneum (SC), the outermost layer previously identified as the limiting barrier, and reach the 
viable epidermis and/or systemic circulation [147]. This effect is dependent upon different factors 
regarding the patient’s skin nature (age, application site, hydration level, etc.), the nature of the 
molecule used (size, lipophilicity, pKa, etc.), and the vehicle itself (lipophilicity, viscosity, interactions  
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with the drug, ability to release the drug, extent of follicular penetration, possible interaction with the 
skin, etc.). The most important systemic side effects that occur as a consequence of high 
glucocorticoid absorption are bodyweight gain, development of diabetes mellitus, production of 
electrolyte imbalance, hypertension, Cushing’s syndrome, osteoporosis, peptic ulcer, growth 
retardation in infants and children, and suppression of the hypothalamic-pituitary-adrenal axis [180, 
181]. Within the local adverse events the most common one observed is cutaneous atrophy [181]. A 
typical disease pattern for this condition is a characteristic reduction in epidermis and SC thickness, a 
decreased number of keratinocytes, changes in the organization of elastin and collagen fibers, a 
decreased cellularity in the dermis, elimination of fatty tissue, and loss of mast cells [98, 99]. Although 
the occurrence of this adverse event is almost unavoidable during frequent application of topical 
glucocorticoids, the degree of it observed in patients can generally be directly related to factors like 
the treated skin site (“thicker” on scalp or forearm vs. “thinner” on eyelid ), patient’s age, potency of 
the drug used, and usage of occlusion [182]. Besides these adverse events there are other major 
drawbacks that physicians and patients describe when employing topical glucocorticoid treatment, 
especially for inflammatory scalp diseases like AA, LPP, or FFA. For example current clinical trials 
employ therapies which involve the application of an ointment containing a glucocorticosteroid (e.g. 
Clobetasol Propionate, CP) to the desired site of action under occlusion with a plastic film, or 
application of a shampoo or cream several times a day [95, 96, 183]. Because these conditions are very 
tedious and time-consuming they are generally not well accepted by the patients resulting in decreased 
patient compliance. Moreover, reaching the desired site of action, e.g. the inflamed region of the hair 
follicle in patients suffering from AA or LPP in a more direct and efficient manner, presents itself as 
being extremely difficult as normal formulations like creams gels do not penetrate well into the hair 
shaft.  
One way to minimize the risk of developing the above mentioned adverse events would be to limit 
dermal permeation as well as limiting the exposure of the skin to high drug concentrations. In 
literature it has been shown that polymeric nanoparticles (NPs) are able to serve as a controlled drug 
release system [100-106]. Hence, a sustained drug release and the resulting avoidance of a burst effect 
would protect the epidermal epithelial regenerative cells from the sudden encounter of high drug 
concentrations, resulting in a reduced risk of developing local cutaneous atrophy and enhanced 
regeneration. Furthermore, Lademann et al. described that poly(lactic-co-glycolic acid) NPs 
accumulate in porcine HFs, and in that sense may serve as a drug delivery system to target this annex 
[184]. They also demonstrated a so-called `depot effect´ of these particles in the HF for up to 10 days, 
while the particles located in the SC were detectable for 24 hours. Consequently, besides the above 
mentioned specific scalp diseases, typical high-prevalence inflammatory skin disorders, e.g. eczema, 
or psoriasis vulgaris, could also benefit from a NP-based glucocorticoid therapy by achieving an  
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accumulation of particles in the hair shaft of vellus and/or terminal HFs, and simultaneously  
penetrating into upper epidermal layers, where they exhibit a steady release of drug over time. 
Due to the above mentioned arguments, it is hypothesized that a NP-based sustained-release 
formulation for CP, a very potent glucocorticosteroid, that decreased skin permeation and facilitates 
follicular targeting is a new and improved strategy to reach the desired site of action for the above 
mentioned conditions in a more efficient and direct way. It is believed that it could decrease, or even 
diminish, those described side effects due to release kinetics and decreased permeation, and potentially 
increase patient compliance in the future. Hence, in this chapter, three different types of polymeric 
NPs (nanospheres (NS), nanocapsules (NC), lipid-core nanocapsules (LNC)) were prepared and 
characterized. The particles were formulated either as an aqueous suspension or as Carbopol® 
hydrogel (HG). Targeted delivery to the HF of the different types of NPs and formulations was 
quantified to determine differences in the extent of follicular uptake between the particles and/or 
formulations. Furthermore, the influence of massage on follicular uptake was evaluated. Lastly, 
experiments with excised human skin were performed to evaluate skin permeation under conditions 
where follicular uptake is considered to be minimal [185].  
2.3.3. Materials and Methods 
2.3.3.1. Materials 
Poly(-ɛ-caprolactone), Clobetasol propionate, Caprylic/capric triglyceride mixture, Polysorbate 80, 
Polyethylene glycol 5400, and sorbitan monostearate were purchased from Sigma-Aldrich (St. Louis, 
MO, USA. Dialysis bags (Spectra Por 7, 10 Kd, Spectrum Laboratories, USA) were purchased from 
Bioagency (SaoPaulo, Brazil) and acetone from Nuclear (Sao Paulo, Brazil). Carbopol
®
 Ultrez 10 was 
purchased from Ginama (Valencia, Spain). Human skin was kindly donated by the Hospital 9 de 
Octubre, Valencia, Spain, and Caritaskrankenhaus, Lebach, Germany, after previous signed consent of 
patients. Pig ears were obtained from Emil Faerber GmbH & Co. KG Zweibrücken (Zweibruecken, 
Germany). Methanol, acetonitrile and ethanol solvents were of HPLC quality and purchased by 
Scharlau (Barcelona, Spain). HPLC water was obtained by MilliQ-purification. 
2.3.3.2. Preparation of Different Nanoparticles in Suspension and             
Hydrogel 
Drug-free and CP-loaded NS, NC, and LNC were prepared using the nanoprecipitation-solvent 
evaporation technique, previously described by Fessi et al. [186], which has been successfully applied 
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to poly(-Ɛ-caprolactone) (PCL) [15, 103, 104]. This polymer was chosen because it is biodegradable 
and has previously been approved by the Food and Drug Administration (FDA) for drug delivery 
specific purposes [187]. The NS represent a matricial system, meaning that the drug is physically and 
uniformly dispersed in the polymer matrix (Figure 25a). The NC and LNC are representative vesicular 
systems, which consist of a polymer shell and an inner core (here consisting of a liquid or an 
organogel, respectively) in which the drug is dissolved (Figure 25b-c).  
 
Figure 25: Depiction of the three different types of nanoparticles prepared. a) shows the nanospheres (NS), which give rise 
to a matrix system, b) nanocapsules (NC), and c) lipid-core nanocapsules (LNC). The latter two consist of a core-and-shell 
structure. 
 
For the preparation of NS, sorbitan monostearate was dissolved in the organic phase along with the 
polymer. NC contained PCL as the polymeric shell and capric/caprylic triglycerides (CCT) as a liquid 
lipid core, and the LNC consisted  of PCL as the polymeric shell, and CCT plus the lipophilic 
surfactant sorbitan monostearate dispersed in the core, forming an organogel [188]. Exact 
concentrations of all components for the three nanocarriers are given in Table 2.  
The LNC suspensions were prepared by dissolving PCL (unlabeled and/or Rhodamin-B labeled as has 
previously been described by Poletto et. al [189]), sorbitan monostearate, and CCT (plus CP in the 
case of the drug-loaded particles) in acetone. This organic solution was injected at a stable, continuous 
speed into the aqueous phase, containing polysorbate 80, under moderate stirring. NS were prepared in 
the same manner minus the addition of the oil phase (medium chain triglycerides), and for the 
preparation of NC, no sorbitan monostearate was added. Acetone was removed using a rotational 
evaporator, and the formulation was concentrated to reach a final volume of 10 ml at 40ºC under 
reduced pressure. As a control, free CP in water/ethanol (50:50) was prepared. All formulations were 
made in triplicates and stored at room temperature (25º C) in amber glass flasks in order to protect the 
fluorescently-labeled polymer from light degradation.  
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Table 2: Concentrations of components of nanospheres (NS), nanocapsules (NC), and lipid-core nanocapsules (LNC) in 
aqueous suspension 
 
Type of 
Particle 
PCL unlabeled 
(mg/ml) 
PCL labeled 
(mg/ml) 
SM   
(mg/ml) 
CCT  
(mg/ml) 
Polysorbate 
80(mg/ml) 
CP    
(mg/ml) 
10% labeled PCL, 
CP-loaded 
NS 9 1 3.8 - 7.7 0.5 
NC 9 1 - 16.0 7.7 0.5 
LNC 9 1 3.8 16.0 7.7 0.5 
100% labeled PCL, 
drug-free 
NS - 10 3.8 - 7.7 - 
NC - 10 - 16.0 7.7 - 
LNC - 10 3.8 16.0 7.7 - 
100% unlabeled PCL, 
CP-loaded 
NC 10 - - 16.0 7.7 0.5 
100% labeled PCL, 
CP-loaded 
NC - 10 - 16.0 7.7 0.5 
PCL, poly(ɛ-caprolactone); SM, sorbitan monostearate; CCT, capric/caprylic triglyceride; CP, clobetasol propionate 
 
The hydrogel (HG) preparation was done by dispersing Carbopol
®
 Ultrez 10 NF at 0.5 % into the 
various NP suspensions (drug-free and drug-loaded NS, NC and LNC). The formulations were mixed 
thoroughly for 5 min to guarantee complete dispersion. To obtain a suitable semisolid formulation for 
dermal application, triethanolamine (0.2 %; w/w) was added for neutralization purposes. For each type 
of NP, a corresponding HG was produced as well containing drug-free particles in order to assure that 
no changes in particle size and polydispersity are brought about via the encapsulation process of drug. 
Additionally, a control HG containing non-encapsulated/free CP, dissolved in water/ethanol (50:50), 
was prepared. All HG were prepared in triplicate, protected from light, and stored at room temperature 
(25ºC). 
2.3.3.3. Particle Characterization 
Size & ζ-potential 
For size, polydispersity and ζ-potential measurements of the three types of NPs, a Zetasizer 
Nanoseries (Malvern Instruments, Worcestershire, UK) was used. The NP suspension-samples and 
HG-samples were diluted 1:500 in aqua dest. for dynamic light scattering (DLS) analysis to measure 
size and the polydispersity index (PDI), and 1:500 in 10 mM NaCl for computing the ζ-potential. Of 
each formulation, three replicates were measured at room temperature. Results are given as mean ± 
standard deviation (SD). 
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Morphology Study 
Morphology of all three types of particles was analyzed using scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM).  
SEM was only possible after a 20.000-fold dilution of the suspension, due to a thick film covering the 
particles, most likely a result of excess polysorbate 80. For the preparation, 10 µl of the diluted NP 
suspensions were added onto supports with carbon-glue, and coated with gold under an argon 
atmosphere using a gold sputter module in a high-vacuum evaporator. Samples were then measured at 
a magnification of 30 k for NS, and 25 k for NC and LNC. The SEM instrument used was an EVO LS, 
Carl Zeiss AG, Oberkochen, Germany. 
Transmission electron microscopy (TEM) images were taken on a transmission electron microscope 
(TEM, JEOL JEM-2011; Jeol GmbH, Munich, Germany; available at the Experimental Physics 
Department, Saarbrücken, Germany), using a voltage of 200 kV at a magnification of 20 k. The NP 
suspensions were first diluted 1:100 in aqua dest., 10 µl were added onto the carbon coated grid and 
left to dry for 2-3 min. Excess of water was removed from the grid using a piece of filter paper. After 
3-5 min, the deposited sample was negatively stained by addition of 10 µl of a 1% phosphotungstic 
acid solution. After 3-5 min, excess of liquid was removed again using a piece of filter paper and the 
samples were allowed to air dry before measuring.  
2.3.3.4. Drug Content and Encapsulation Efficiency  
In order to assure that no drug loss occurred during the production of the NP suspensions,  CP content 
of all three particle suspensions was analyzed following a slightly modified version of the method 
described by Fontana et al. [190]. Hence, 1 ml of each suspension, or 1 mg of each HG, was dissolved 
in 25 ml acetonitrile (ACN) (instead of methanol), and the mixture was sonicated for 20 min. Samples 
were analyzed by means of HPLC. Moreover, the encapsulation efficiency of the samples was 
determined. For that the samples were centrifuged (Ultrafree-MC 10,000 MW, Millipore) at 12,000 
rpm for a period of 5 min, and the ultrafiltrate was quantified for CP. To determine CP content in the 
particles, the difference between the total drug and the ultrafiltrate concentration was calculated. The 
encapsulation efficiency (EE %) was then calculated by dividing the drug entrapped by the total drug 
content. All measurements were made in triplicate, and samples were analyzed by means of HPLC. 
For the analysis a Kromasil® RP-18 column (5 µm particle size, 100 Å pore size, 150 x 4.6 mm) was 
used as the stationary phase and ACN:H2O (65:35 v/v) as the corresponding mobile phase with a flow 
rate of 1 ml/min. UV detection was set at 240 nm with a column temperature of 30°C, and an injection 
volume of 20 µl. 
 
FOLLICULAR TARGETING AND INTERFOLLICULAR PERMEATION  
OF CLOBETASOL NANOCARRIERS  
- 67 - 
 
 
2.3.3.5. Stability Study 
To assure stability of the formulations over a period of time, suspensions in water (0.5 g/ml CP) were 
stored for 3 months after preparation and monitored in terms of particle size, PDI, ζ-potential, and pH. 
The samples were stored in amber glass flasks, protected from light, at room temperature. 
2.3.3.6. Drug Release Study 
For the determination of CP release from the three different particles, experiments were performed by 
means of the dialysis bag method using water/polysorbate 80/PEG 400 (60:0.5:40 v/v) as the receptor 
medium [191]. This receptor medium was chosen for comparison purposes due to previously 
published release data, in which the same particles loaded with a different drug  were used [190]. The 
components polysorbate 80 and PEG 400, at the concentrations stated above, were added in order to 
assure sink conditions during the experiment [102]. Stability of CP in the above described release 
medium was previously evaluated using HPLC, and no degradation of CP was observed for up to 72 
hours (data not shown). In short, 1 ml (0.5 mg/ml CP) of each NP suspension was pipetted into a 
dialysis bag (Spectra Por 7, 10 Kd). This dialysis membrane (molecular weight cut off: 10,000 Dalton) 
was chosen because it is only permeable to free CP, but not to the NPs. Hence, only free drug that has 
been released from the particles and permeated into the receptor medium will be quantified. The bag 
filled with sample was then placed into a 250 ml Erlenmeyer flask containing 200 ml of the previously 
mentioned receptor medium. 1 ml samples of this medium were withdrawn after 2, 4, 6, 8, 24, 30, 48, 
54, and 72 hours and immediately replaced by fresh medium. The CP concentration of each sample 
was determined via HPLC using the same method as described above [190]. As a control, 0.5 mg/ml 
CP dissolved in an ethanolic solution was prepared and tested accordingly. 
2.3.3.7. Follicular uptake studies 
The extent of follicular uptake for each type of particle (NS, NC, and LNC in suspension and in HG) 
was analyzed and assessed quantitatively on porcine ear skin based on the differential stripping (DS) 
method [118]. As a control, free drug in solution and free drug in HG were tested, too, in order to 
determine whether CP delivery to the HF is in fact enhanced by means of encapsulation. 
Differential Stripping Method 
The differential stripping (DS) method is the most straightforward technique to determine follicular 
uptake quantitatively, as has recently been described by Raber et al. [86]. Since it has already been 
introduced in Chapter 1, it is only described here shortly.The formulation is first applied onto a 
predetermined area on the skin, followed by an optional 3 min massage, depending on the desired 
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experimental setup. The massage is performed using a gloved forefinger and massaging in a circular 
motion (60 rpm) for 3 min with applied pressure (~2 N). To minimize deviation, all DS experiments 
were done by one well-trained person. After 1 hour incubation, 10 subsequent tape strips (Tesa® 
adhesive tape) are taken to clean the skin surface by removing the SC layer by layer, followed by 2 
cyanoacrylate skin surface biopsies which enable the removal of the entire follicular content [192]. All 
tape strips and cyanoacrylate biopsies were pressed onto the skin using a roller to stretch the skin 
surface and guarantee reaching the skins wrinkles and furrows [193]. For quantification and mass-
balance purposes, all tape strips and cyanoacrylate biopsies, along with all used application devices 
and skin rest, were extracted in ACN, centrifuged at 20°C using 12.000 rpm for five minutes, and 
analyzed for fluorescence (Rhodamin-B labeled PCL) or CP content (see Section: Quantification 
Methods for Follicular Uptake Studies for specifics on analytic).  
Follicular Uptake of Drug-free Particles 
Preliminary follicular uptake studies of drug-free NS, NC, and LNC were performed in order to 
determine whether the type of nanocarrier and their differeing molecular architecture affect the uptake 
into the HF. Quantification of these drug-free particles was possible via fluorescence measurements, 
as Rhodamin-B labeled PCL was used for the preparation. Previous experiments had demonstrated 
that the amount of labeled PLC in the HF was below the detection limit when NPs were prepared 
using only 10% of the Rhodamin-B labeled PCL and 90% unlabeled (as was used for skin permeation 
experiments below), therefore all nanocarriers used for follicular penetration studies that were 
quantified via fluorescence were prepared using 100% labeled PCL. The composition of all particles is 
given in Table 2. Besides determining the influence of the type of particle and type of formulation on 
follicular penetration, the influence of a 3 min massage was evaluated as well. Each formulation was 
tested on two separate pig ears, each ear containing three areas of formulation, and one blank. n=6 for 
each.  
Follicular Uptake of Clobetasol-loaded Nanocapsules 
After these preliminary experiments using drug-free particles, NC in suspension were chosen as the 
best formulation for obtaining the highest follicular uptake. To evaluate delivery of encapsulated CP to 
the HF, this formulation loaded with 0.5 mg/ml CP was then tested using the DS method (including a 
3 min massage) and follicular uptake was quantified based on CP content using LC-MS, rather than 
the fluorescently labeled polymer. n=6. 
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Follicular Uptake of Clobetasol and Polymer Simultaneously 
To investigate whether changes in size influence the extent of follicular uptake, smaller CP-loaded 
NCs were prepared by increasing the stirring speed during the addition of the organic phase into the 
aqueous phase. As we were interested in co-tracking drug and polymer simultaneously, the CP-loaded 
particles were prepared using 100% Rhodamin-B labeled polymer. Follicular uptake was quantified 
based on drug content and labeled polymer for the same sample set. n=6. 
Follicular Uptake of Free Clobetasol in Solution and Hydrogel  
For control experiments free CP in an ethanolic solution (0.5 mg/ml) and free CP in HG (0.5 mg/g) 
were applied onto porcine ear skin and follicular uptake was evaluated. n=6. 
Quantification Methods for Follicular Uptake Studies 
Fluorescence 
All fluorescence measurements were performed using a Cytofluor II fluorescence plate reader (λexc = 
560 nm, λem = 662 nm) [189]. The lower limit of quantification (LLOQ), important for determining 
the analytical limitations of the quantification method [86], was calculated based on the fluorescence 
of the blanks plus the background fluorescence of the different types of matrices (tape strips, 
application devices, cyanoacrylate biopsies). The LLOQ was previously determined for each type of 
matrix.  
LC-MS 
LC-MS analysis and quantification for follicular uptake of the CP-loaded NC was carried out using a 
TSQ Quantum Access Max (Thermo Fisher Scientific) tandem quadrupole mass spectrometer coupled 
to an Accela UHPLC system. The whole system consists of a quaternary mixing pump with a built-in 
solvent degassing system, thermostated autosampler and column oven. An Accucore RP-MS column 
(150 mm x 2.1 mm, 2.6 µm, Thermo Fisher Scientific, Waltham, MA, USA) was implemented, which 
was set at 30°C during the experimental run. The system was operated by the standard software 
Xcalibur. A method described by Nam et al. was used with slight modification [194]. The LC system 
was run isocratically for 5 minutes at 400 µl/min using acetonitrile + 0.1% formic acid and water + 
0.1% formic acid (65:35). Heated-electrospray ionization (H-ESI) in positive mode was used. The 
optimized H-ESI conditions were: capillary voltage of 4500 V, vaporizer temperature of 500 °C, ion 
transfer tube temperature of 350 °C. Nitrogen was used as sheath and auxiliary gas, and the settings 
were of 40 and 5 (arbitrary units), respectively. Quantitation was performed operating in selective 
reaction monitoring (SRM) mode.  Observed ions were as follows (values are given for mother ion 
[m/z]; collision energy [V]; product ion [m/z]; scan time [s]; scan width [m/z]: 467; 12; 355; 0.2; 0.02. 
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The method was previously validated over a concentration range of 3.0-200.0 ng/ml (samples were 
diluted prior to measuring accordingly) with a correlation coefficient of r
2 = 
0.9995. 
Recovery (%) 
Total recovery (%) was calculated for each performed experiment using a mass-balance. Based on the 
guidelines of the Scientific Committee on Consumer Safety (SCCS) only data which fit the recovery 
limits of 85-115% were evaluated [195]. 
2.3.3.8. Skin Permeation Studies 
The skin was obtained from the Hospital 9 de Octubre, Valencia, Spain, and from the Department of 
Plastic and Hand Surgery at the Caritaskrankenhause in Lebach, Germany, after written consent was 
obtained from the patients. The epidermis was separated from the dermis using the well-adapted 
method first described by Kligmann et al. in 1963 [196]. In short, a previously cut skin section (25 
mm in diameter) is placed into 60°C aqua dest. for 90 sec to weaken epidermal-dermal junction. Next, 
the epidermis is carefully peeled off using two anatomical forceps and placed into PBS buffer until 
use. This study was approved by the ethical commission of Saarland, Germany (Aerztekammer des 
Saarlandes, 204/08). 
The acceptor compartment of the Franz cells was filled with an ethanol/phosphate buffer solution 
mixture (50:50) to assure sink conditions, and placed into a preheated incubator at 32°C to maintain 
the physiologic temperature of the skin throughout the experiment. The previously heat-separated 
epidermis (HSE) was placed onto a Whatman
®
 filter
6
 with the SC facing upwards for additional 
support, and positioned on top of the acceptor compartment to separate it from the donor compartment 
(refer to Figure 6). After a 30 min acclimatization period, 1 ml of each nanoparticle suspensions (NS, 
NC, and LNC) or control were pipetted into the donor compartment of the cells. The gels (0.5 g), in 
contrast, were evenly spread onto the membrane surface to cover the complete diffusion area. Both 
compartments were held together using a clamp. In addition, the donor compartment was sealed off 
using Parafilm
®
 to avoid evaporation of the ethanol in the receptor medium. Samples were taken from 
the receptor compartment after predetermined time intervals followed by an immediate replacement of 
the removed volume by fresh buffer. Subsequently the samples were analyzed by HPLC using the 
method described above and the cumulative amounts of CP permeated into the receptor compartment 
were calculated [190]. n≥6 for each formulation. 
 
                                                     
6
 Previous experiments had demonstrated that this filter membrane did not limit permeability of the substance 
(data not shown) 
FOLLICULAR TARGETING AND INTERFOLLICULAR PERMEATION  
OF CLOBETASOL NANOCARRIERS  
- 71 - 
 
2.3.3.9. Statistical Analysis 
Results are expressed as the arithmetic mean ± SD. Significant differences between formulations were 
investigated by means of one-way analysis of variance (ANOVA) and two-way ANOVA (using 95% 
confidence interval) for all follicular uptake data, and Student’s t-test (two-sided, unpaired, with 
Welch's correction, p < 0.5) for determination of intra-individual variability of permeability data in 
vitro. All statistical analysis was done using the software SigmaPlot (version 12.5, from Systat 
Software, Inc., San Jose California USA). 
2.3.4. Results and Discussion 
2.3.4.1. Size Distribution and ζ-Potential  
The sizes measured for the three different types of particles ranged between ~100 - 260 nm (see Table 
3 for exact values).  As previously mentioned, a smaller sized-set of CP-loaded NC particles (106 nm) 
was prepared to evaluate if size is a key factor in deciding the extent of follicular penetration. 
Table 3: Size distribution, PDI values, and ζ-potential of nanospheres (NS), nanocapsules (NC), and lipid-core nanocapsules 
(LNC) in suspension using dynamic light scattering (DLS) analysis; mean ± standard deviation. 
 
NC and LNC gave rise to a generally larger size when compared to NS. This can be explained by the 
presence of the oil phase [197] leading to a core-and-shell structure for NC and LNC instead of a 
matrix system (NS). All suspensions had a PDI between 0.06 and 0.19 confirming a homogeneous size 
 
Type of 
Particle 
DLS 
(nm) 
PDI 
ζ-potential 
(mV) 
CP Content 
(mg/ml) 
Encapsulation 
Efficiency (%) 
10% labeled PCL 
90% unlabeled PCL 
CP-loaded 
NS 176 ± 07 0.12 ± 0.04 -12.17 ± 1.11 0.48 ± 0.02 98.46  ± 1.0 
NC 218 ± 02 0.18 ± 0.01 -10.38 ± 0.69 0.50 ± 0.01 98.25 ± 0.8 
LNC 222 ± 14 0.19 ± 0.06 -12.03 ± 1.12 0.51 ± 0.01 97.92 ± 0.3 
100% labeled PCL 
drug-free 
NS 128 ± 02 0.17 ± 0.02 -13.59 ± 0.73 - - 
NC 257 ± 11 0.15 ± 0.01 -14.42 ± 1.09 - - 
LNC 157 ± 04 0.14 ± 0.01 -13.29 ± 1.27 - - 
100% unlabeled 
PCL, 
CP-loaded 
NC 221 ± 07 0.06 ± 0.03 -12.21± 0.73 0.50 ± 0.03 98.45 ± 0.4 
100% labeled PCL 
CP-loaded 
NC 106 ± 01 0.08 ± 0.01 -13.22 ± 0.34 0.51 ± 0.01 98.76 ± 0.7 
PCL, poly(ɛ-caprolactone); CP, clobetasol propionate 
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distribution. The ζ-Potential of all three types of NPs was negative, ranging from -10.0 to -14.5 mV. 
This negative potential is most likely caused by the polymeric wall formed by poly(ɛ-caprolactone) 
[198]. The stability of the particles in suspension is, thus, a result of steric hindrance of the surfactant 
between the two phases preventing coalescence [199]. 
2.3.4.2. Drug Content & Encapsulation Efficiency  
The CP content quantified was approximately 0.5 mg/ml for all three nanocarriers, showing that no 
drug was lost during the preparation step for NS, NC, or LNC. Moreover, the encapsulation efficiency 
(EE %) measured was close to 100%, regardless of the type of particle (for exact values please refer to 
Table 3). Hence, no significant differences regarding the ability to encapsulate the drug were observed 
between NS, NC, or LNC, although the preparation processes and components used were slightly 
different.  
2.3.4.3. Morphology  
Scanning electron microscopy (SEM) and transmission electron microscopic (TEM) analysis were 
feasible for all three types of particles (see Figure 26).  
 
Figure 26: SEM images of NS (a), NC (c), and LNC (e) in suspension; TEM images of NS (b), NC (d), and LNC (f) in 
suspension. Scalebars in a, c, and e represent 400 nm and image was taken with 25 k magnification. Scalebars in b, d, and f 
represents 200 nm and image was taking using a voltage of 200 kV at a magnification of 20 k. 
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However, for LNC the imaging was more difficult, most likely due to the presence of the organogel. 
Both methods confirmed the expected morphology. All particles were spherical in shape, revealed a 
smooth surface, and a homogeneous size distribution. Figure 26 displays SEM (a,c,e) and TEM (b,d,f) 
images of all three particles (NS, NC, and LNC) in suspension, respectively.  
2.3.4.4. Stability Study 
Stability of the NPs in suspension was tested for a period of 3 months in terms of size, polydispersity, 
ζ-potential, and pH (see Table 4). After this period a slight increase in particle size was observed, most 
likely due to aggregation or agglomeration.  However, this effect was minimal and negligible. The ζ-
potential varied marginally over time with no general trend observed. The pH study demonstrated that 
the pH values obtained were suitable for application on the skin over the entire period of three months, 
as the pH stayed between pH 5.1 - 6.1. A slight reduction in pH was observed, but still remained 
adequate for topical application. This effect has previously been explained as a possible degradation of 
the polymer due to a release of free ɛ-hydroxycaproic, as well as a hydrolysis of the medium chain 
triglycerides, leading to an increase of free fatty acids [199]. Thus, all measurements confirmed that no 
noteworthy changes in size, polydispersity, ζ-potential, or pH occurred over time. 
Table 4: Physiochemical characteristics of nanospheres (NS), nanocapsules (NC), and lipid-core nanocapsules (LNC) 
suspensions tracked for 3 months; mean ± SD (size measured using DLS analysis) 
Type of 
Particle 
Month 
Size  
(nm) 
PDI 
ζ -Pot  
(mV) 
pH 
NS 0 158 ± 2 0.09 ± 0.02 -14.40 ± 1.75 6.12 ± 0.23 
NS 1 169 ± 1 0.12 ± 0.03 -11.90 ± 1.59 5.86 ± 0.13 
NS 2 167 ± 9 0.14 ± 0.05 -11.47 ± 1.84 5.53 ± 0.26 
NS 3 173 ± 7 0.14 ± 0.03 -13.49 ± 1.09 5.50 ± 0.14 
NC 0 195 ± 4  0.08 ± 0.02 -12.10 ± 1.93 5.99 ± 0.23 
NC 1 218 ± 3 0.16 ± 0.02 -10.30 ± 1.71 5.92 ± 0.19 
NC 2 208 ± 4 0.13 ± 0.03 -13.63 ± 0.65 5.42 ± 0.12 
NC 3 223 ± 10 0.14 ± 0.04 -13.39 ± 2.57 5.25 ± 0.13 
LNC 0 193 ± 3 0.08 ± 0.04 -10.60 ± 3.43 6.11 ± 0.21 
LNC 1 217 ± 3 0.15 ± 0.03 -12.46 ± 2.52 5.90 ± 0.11 
LNC 2 209 ± 3 0.16 ± 0.02 -14.31 ± 1.91 5.92 ± 0.19 
LNC 3 216 ± 10 0.16 ± 0.04 -12.11 ± 1.64 5.11 ± 0.10 
          PDI, polydispersity index ζ –Pot, zeta potential 
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2.3.4.5. Hydrogel Characterization  
A summary of the hydrogel characterization is given in Table 5. The pH values of the Carbopol
®
 HG 
measured were between 5.6 and 6.7, yielding a suitable pH for topical administration of semisolid 
formulations [200].  
Table 5: Hydrogel (HG) Characterization; mean ± SD. 
 Type of 
Particle 
pH 
Size 
(nm) 
CP content 
(mg/g) 
10% labeled PCL 
CP-loaded 
 
NS-HG 5.61 ± 0.22 183 ± 17 0.51 ± 0.01 
NC-HG 6.05 ± 0.11 219 ± 15 0.51 ± 0.01 
LNC-HG 5.90 ± 0.12 230 ± 18 0.52 ± 0.03 
CP-HG 5.87 ± 0.18 - - 
100% labeled 
drug-free 
NS-HG 5.92 ± 0.31 185 ± 2.05 - 
NC-HG 6.73 ± 0.57 206 ± 2.61 - 
LNC-HG 6.03 ± 0.42 143 ± 1.11 - 
     NS, nanospheres, NC, nanocapsules, LNC, lipid-core nanocapsules, CP, Clobetasol propionate, PCL, poly(ɛ-caprolactone) 
The presence of the drug did not alter the pH of the HGs for any of the formulations (p>0.05 for each 
formulation). The sizes of the particles in the HGs were still in the same range as the original 
suspensions, and drug content remained close to the desired CP concentration of 0.5 mg/g for all 
formulations.  
2.3.4.6. Drug Release Study 
To determine whether the encapsulation process results in a sustained release of drug, the dialysis bag 
method was applied. Figure 27 depicts the release profiles of the three different NPs in suspension 
(NS, NC, LNC) vs. free drug in an ethanolic solution as a control. As can clearly be seen in Figure 27, 
no significant differences were observed between the release profiles of the three nanocarriers NS, 
NC, or LNC (p>0.05). However, as was anticipated, all three CP-loaded particles revealed a sustained 
release of the drug, as after 24 h only approximately 50% of the encapsulated drug was released for all 
three carriers. Even at the end of a 72 h period, the mean amount of released drug still remained below 
80%. Free drug, in contrast, revealed a fast release profile with ~80% of CP already being detected 
after only 5h.   
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Figure 27: Release profiles of Clobetasol (CP) from nanoparticle formulations nanocapsules (NC), nanospheres (NS), lipid-
core nanocapsules (LNC) compared to free drug (CP) (mean ± SD). 
 
2.3.4.7. Follicular Uptake Studies 
The detection limit of quantification for all three NPs in suspension was as low as 0.3-0.7%, and for 
the particles in HGs ≤ 0.2% of the total amount applied in all matrices (tape strips, cyanoacrylate 
biopsies, application devices, skin rest). Thus, the goal to detect < 1.0%, set due to previous results in 
follicular uptake studies [86], was achieved for all NPs in suspension, as well as in HG. 
Follicular Uptake of Drug-Free Particles 
Follicular uptake of the drug-free particles, with and without the application of a massage, is depicted 
in Figure 28. Figure 28a) displays the recovery (w/w %) in the HF of the total amount applied for the 
three types of drug-free nanocarriers (NS, NC, LNC; suspension vs. HG) when no massage was 
applied. For this specific experimental setup NC presented a significantly higher recovery in the HF 
for both formulations in comparison to NS and LNC (two-way ANOVA, p<0.05) (also see Table 6 for 
exact values). However, no significant difference was observed between the two types of dosage 
forms. 
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Figure 28: Recovery (%) in hair follicles of total amount applied of blank NS, NC, and LNC formulated as suspension and 
hydrogel without application of massage in a) and after application of massage depicted in b); * represents statistical 
significance between types of particles (NC vs. NS and NC vs. LNC), x represents statistical significance between 
formulation (in suspension vs. in hydrogel) 
 
Figure 28b) displays the results obtained for the follicular uptake experiments when a 3 min massage 
was performed before incubation. A similar trend with a generally higher recovery of the particles in 
the HF can be seen with the additional massage. Again, NC demonstrated a significantly higher 
follicular uptake when compared to NS and LNC (two-way ANOVA, p<0.05) for both formulations. 
Moreover, the positive effect of a massage on follicular penetration, which was also observed in this 
study, has previously been discussed in literature by Lademann et al. [184]. In this work the authors 
hypothesize that the moving of the hair, which is an effect caused by the massage, acts like a so-called 
‘gear pump’, resulting in an increased transport or translocation of the particles into the hair shaft. It 
therefore mimics the natural movement of the hair.  
A reason for the higher accumulation of NCs as opposed to NS in the HF shaft could be related to the 
differences in their supramolecular organization. NCs represent a rather flexible core-and-shell 
structure, whereas NS give rise to a rigid matrix system. Differences in follicular penetration between 
the two core-and-shell systems, NC and LNC, could be attributed to the difference in the core 
viscosity and resulting flexibility. The NC core consists of mainly oil (medium chain triglycerides), 
resulting in a liquid lipid, whereas the LNC core additionally contains the lipophilic surfactant sorbitan 
monostearate. This surfactant, in presence of the oil, acts like a low molecular mass organic gelator, 
resulting in the formation of an organogel [198, 201, 202] (see Figure 25 for schematic depiction of 
particles). In a previous study using almost equivalent NC and LNC particles (only differing in the 
drug encapsulated), it was shown that the LNC, comprising this organogel core, exhibited a stiffness  
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(based on the calculated Young’s modulus MPa) almost twice as high as was measured for the NC 
using atomic force microscopy (AFM) [198]. Thus, it can be speculated that a higher follicular 
penetration may be achieved by using more flexible particles. Regarding the dosage form, the particles 
formulated in a HG resulted in an overall statistically significant lower uptake in comparison to 
particles formulated in a suspension regardless of the application of massage (two-way ANOVA, 
p<0.05). This could be related to viscosity differences which may lead to difficulties of the NPs 
leaving the more viscous matrix during the incubation time.  
 
Table 6: Recovery in hair follicle (w/w%) of total amount applied for different types of particles with and without 
application of massage as well as controls (CP in solution vs. CP in hydrogel); mean ± standard deviation. 
Particle Information 
Recovery (%) in hair follicle 
without massage 
Recovery (%) in hair follicle  
with massage 
Aqueous Suspension Hydrogel Aqueous Suspension Hydrogel 
NS drug free 0.88 ± 0.48 0.48 ± 0.49 1.73 ± 0.33 x 0.91 ± 0.51 
NC drug free 1.61 ± 0.54* 1.21 ± 0.23* 3.06 ± 1.03 x,* 1.32 ± 0.56* 
LNC drug free 0.64 ± 0.09 1.02 ± 0.04 1.84 ± 0.63 x 0.70 ± 0.11 
 
Recovery (%) in hair follicle 
without massage 
Recovery (%) in hair follicle 
with massage 
CP in ethanolic solution < LLOQ < LLOQ 
CP in hydrogel < LLOQ < LLOQ 
*represents statistically significant difference between types of particles (NC vs. NS and NC vs. LNC) p<0.05 
 x represents statistical significant difference between formulation (in suspension vs. in hydrogel) p<0.05 
 
Follicular Uptake of Clobetasol-loaded Nanocapsules, and Free Clobetasol in 
Solution and Hydrogel 
To confirm that the amount of polymer which we have quantified in the HF is also representative of 
the amount of encapsulated drug reaching the desired site of action, we compared the uptake of 
similarly sized drug-free NC and drug-loaded NC in suspension via fluorescence and LC-MS, 
respectively. A very good correlation was observed for the detected amount of polymer and drug, as 
can be seen in Table 7 (3.06 ± 1.03 % vs. 3.29 ± 0.53 % recovery in HF of total amount applied). 
Also, the smaller NC with an average size of 106 nm were taken up similarly as the original NC of 
size 257 nm (2.98 ± 0.65 % and 3.09 ± 0.17 % vs. 3.06 ± 1.06 %). Lastly, no significant difference in 
the amount detected was observed when comparing the two quantitation methods (fluorescence vs. 
LC-MS) for the same sample set of the smaller NCs (p>0.05).  
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Table 7: Type of formulation and recovery (w/w %) in hair follicle of total amount applied for differently formulated  
and quantified nanocapsules (NC) in suspension; mean ± SD. 
Type PCL 
Size 
(nm) 
Quantification Method 
Recovery (%) in hair follicle 
of total amount applied 
drug-free NC 
100%  
labeled 
257 Fluorescence 3.06 ± 1.03 
CP-loaded NC 
100% 
unlabeled 
221 LC-MS 3.29 ± 0.53 
CP-loaded NC 
100% 
 labeled 
106 
Fluorescence 2.98 ± 0.65 
LC-MS 3.09 ± 0.17 
CP, Clobetasol propionate 
*represents statistically significant difference between types of particles (NC vs. NS and NC vs. LNC NC vs. controls)     
   p<0.05 
 x represents statistical significant difference between formulation (in suspension vs. in hydrogel) p<0.05 
 
Although a size-dependent effect in the extent of follicular penetration was expected due to previous 
studies by other groups [84], the small range in particle size (106 - 257 nm) investigated in this study 
may be the reason that this effect was not observed. To investigate this topic further, a larger range in 
particle size, e.g. ~100 nm – 2 µm, should be tested in the future. 
As for the controls, follicular recovery (%) of the total amount applied of free CP in solution and free 
CP in HG, with and without the application of massage, was below the lower limit of quantification 
(LLOQ) and thus negligible [86, 184, 203]. This confirms that by means of encapsulation a more 
targeted delivery to the HF was achieved.  
Recovery 
Total mass balance was calculated for each above mentioned experiment, and the total recovery (w/w 
%) for all included formulations ranged between 86-110%, fitting well within the limits of recovery of 
85-115% given by the SCCS [195]. 
Summarizing this section, follicular penetration studies revealed that all three types of nanocarriers are 
able to achieve a better and more targeted delivery to the HF when compared to free drug in solution 
or HG. It was demonstrated that the three types of nanocarriers exhibited different penetration 
behaviors, with NCs achieving the highest follicular recovery of up to 4% when applied as an aqueous 
suspension. This only further emphasizes the possible influence of molecular organization on the 
penetration into the HF. This uptake effect was even amplified after application of a massage, as was 
expected. One thing to consider regarding the potential of these particles from a clinical perspective is 
that all follicular uptake studies described herein were performed on the porcine ear skin model. As 
previously mentioned, in vitro follicular uptake experiments on excised human skin are not feasible, as  
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excision results in immediate contraction and closure of the HFs [185]. So even though an excellent 
correlation between pig ear tissue in vitro and human forearm skin in vivo has been established by our 
group regarding the penetration of nanoparticles into the HF [86], the amount of terminal HFs 
available for this kind of therapy on the average human scalp (site of action for most inflammatory-
based hair disorders) is much higher than what is seen on porcine ear skin (124-200 hairs/cm
2
 on 
human occipital scalp vs. 11-25 hairs/cm
2
 on porcine ear skin) [109, 204, 205]. In that sense a 
substantially higher follicular recovery is to be expected in vivo, only further corroborating the 
potential of this form of application for hair disorders like AA, LPP, or FFA. 
2.3.4.8. Skin Permeation Studies 
As a substantial amount of formulation was shown to not penetrate into the HF, and we were 
interested in testing the ability to lower dermal permeation in general, Franz Diffusion cell studies 
were performed using HSE assuming that the follicular pathway is negligible [185, 206]. Figure 29 
displays the resulting permeation profiles (exact amounts can be found in Table 8).  
 
 
Figure 29:  a) depicts permeability through HHSE of free Clobetasol (CP) in solution, free CP in Hydrogel, and CP 
encapsulated into three nanocarriers (nanospheres, NS; nanocapsules, NC; lipid-core nanocapsules, LNC) formulated as 
suspensions; b) shows permeability through HHSE of free CP in solution, free CP in Hydrogel, and CP encapsulated into NS, 
NC, and LNC formulated as Hydrogels (mean ± SD). 
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Figure 29a) depicts the permeated amount of free CP in solution and free CP in HG vs. permeated CP 
after being encapsulated into the three nanocarriers (NS, NC, LNC) and formulated as suspensions. 
Figure 29b) shows the same scenario, except here the nanocarriers are formulated as a HG as opposed 
to a suspension. In both, Figure 29a) and b), the incorporation of free CP into a HG results in a 
significantly less amount of permeated CP to about 50% with respect to free CP in solution, hence the 
rate of permeation is decreased (p < 0.05). Similarly, among the three nanocarriers a statistically 
significant lower cumulative amount was observed when the viscosity of the medium was increased, 
yielding a decreased permeation (p < 0.05). Nonetheless, between the three types of particles no 
significant differences were detected when they were formulated alike (p > 0.05). These results are in 
accordance with the previously discussed release profiles of CP from NS, NC, and LNC, in which also 
no differences was to be detected. Comparing the permeation profiles of the drug after it has been 
encapsulated into the particles and non-encapsulated CP in solution, however, a clear and significant 
decrease in dermal permeation was achieved by means of encapsulation, as was desired.  
 
Table 8: Mean cumulative amounts of Clobetasol (CP) permeated (µg/cm2) for nanospheres (NS), nanocapsules (NC), and lipid-core 
nanocapsules (LNC) in suspension as well as in hydrogel. Results presented as mean ± SD. 
 Cumulative amount of Clobetasol permeated (µg/cm2) 
Sample 
Time 
(hour) 
Free Drug 
Solution 
Free Drug 
Hydrogel 
NS 
Suspension 
NC 
Suspension 
LNC 
Suspension 
NS 
Hydrogel 
NC 
Hydrogel 
LNC 
Hydrogel 
2 0.46 ± 0.03 0.60 ± 0.16 0.20 ± 0.01 0.17 ± 0.10 0.21  ± 0.05 0.00 ± 0.00 0.07  ± 0.03 0.00  ± 0.00 
4 1.62 ± 0.56 1.02 ± 0.35 0.31 ± 0.03 0.25 ± 0.13 0.27  ± 0.06 0.03 ± 0.02 0.19  ± 0.09 0.01  ± 0.01 
6 1.96 ±  0.48 1.34 ± 0.44 0.36 ± 0.02 0.42 ± 0.15 0.36  ± 0.07 0.08 ± 0.07 0.21  ± 0.08 0.03  ±  0.02 
8 2.49 ± 0.53 1.73 ± 0.58 0.41 ± 0.07 0.49 ± 0.20 0.46  ± 0.10 - 0.29  ± 0.16 - 
22 12.69 ± 0.87 6.19 ± 0.83 2.37 ± 0.47 3.03 ± 1.53 3.00  ± 0.80 0.94 ± 0.07 0.85  ± 0.38 - 
24 13.20 ± 1.13 6.82 ± 1.46 3.14 ± 0.48 3.33 ± 1.57 3.06  ± 0.58 1.10 ± 0.06 1.00  ± 0.39 1.16  ± 0.26 
26 14.48 ± 1.42 7.12 ± 1.66 3.20 ± 0.54 3.69 ± 0.77 3.37  ± 0.58 1.19 ± 0.14 1.09  ± 0.45 1.39  ± 0.32 
28 14.38 ± 1.22 7.88 ± 1.38 3.66 ± 0.80 3.81 ± 1.90 3.69  ± 0.53 1.31 ± 0.06 1.35  ± 0.46 1.55  ± 0.35 
30 16.32 ± 1.41 8.64 ± 1.17 3.90 ± 0.80 3.83 ± 1.83 4.28  ± 0.48 1.40 ± 0.05 1.36   ± 0.58 1.60  ± 0.32 
32 17.07 ± 1.41 9.15 ± 1.37 4.33 ± 0.89 4.79 ± 1.07 4.66  ± 0.54 1.49 ± 0.04 1.43  ± 0.55 1.77  ± 0.41 
 
 
One thing to keep in mind is that all results described in this study were done under in vitro conditions 
and may not be 100 % predictive of the in vivo situation, as results obtained under these conditions are 
known to generally overestimate the observed effect [207]. This is most likely due to the non-existing 
clearance in vitro, as well as the ongoing desquamation process in living tissue. Nonetheless, the 
general trend observed is indeed representative and to be expected under real-life conditions. Thus, the  
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observed decreased interfollicular permeation of CP that is achieved via encapsulating the drug into 
the various nanocarriers is beneficial in two ways. For one, less free drug is available to diffuse 
through the skin and enter the blood stream resulting in adverse events, and secondly the particles 
which to penetrate into the skin (or hair shaft) reside in the upper epidermal layers where they release 
the drug steadily over time. 
 
2.3.4.9. Interplay of Follicular Uptake and Non-follicular Permeation 
Modulating the interplay of non-follicular permeation and follicular uptake via the application of 
nanocarriers could be a new, revolutionizing strategy to treat many different skin and/or scalp diseases 
in the future. As was previously hypothesized, the data obtained from the follicular uptake and skin 
permeation studies confirmed that it is indeed possible, depending on the type of carrier and/or vehicle 
used, to vary the treatment based on the desired therapy. For example, one can maximize follicular 
uptake, and simultaneously decrease skin permeation and release of drug into the interfollicular 
epidermis, by using a carrier with the highest follicular delivery, decreased skin permeation, and a 
simultaneous sustained release effect, as in the case of the NC suspension. This could be 
revolutionizing for the treatment of various hair disorder therapies like AA, LPP, or scalp psoriasis, as 
well as more prevalent conditions like atopic dermatitis and psoriasis [95-97, 183].  
2.3.5.     Conclusion 
In conclusion, the potent glucocorticosteroid CP could successfully be formulated into three different 
types of poly-Ɛ-caprolactone NPs. All particles exhibited a sustained release of drug over a period of 
72 h, as was desired. Concerning targeted delivery to the HF, a reoccurring difference in the degree of 
follicular uptake between the various types of NPs could be detected, with NC displaying a 
significantly higher uptake when compared to NS and LNC, in suspension as well as in HG. A 
formulation-dependent trend was also observed, with a generally higher uptake for particles 
formulated as a suspension rather than a HG. This effect was even amplified by the application of a 3 
min massage before incubation. Inter-follicular skin permeation was reduced in an equivalent manner 
for all three types of NPs. Thus, the information learned from this study about the possibility of 
modulating the interplay between follicular uptake and non-follicular skin permeation could be applied 
to provide a more patient-specific and desired therapy under optimized conditions in the future. For 
now, the information obtained from the present in vitro study is a good start for facilitating the 
translation of CP nanocarriers as a means to minimize adverse effects into clinical testing.  
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The presented work illuminates the suitability and applicability of the porcine ear skin model for the 
testing of follicular tight junction (TJ) functionality and the evaluation of nanoparticle-based delivery 
systems via the hair follicle. Special emphasis was placed on the comparison and equivalency between 
the porcine and human hair follicle, as all obtained data in vitro and/or ex vivo should ideally help the 
investigators to gain insight on the in vivo situation. Furthermore, the combination of acquired 
knowledge about the suitability, along with predictions gained from the accumulated data in vitro, is 
crucial when considering the translation of follicular uptake experiments of any kind into clinical 
testing. 
The determination of suitability and equivalency of the porcine ear skin model in comparison to 
human skin was one of the main aims of this work. Thus, as presented in the first section of this thesis, 
a chemically selective and non-destructive analysis of human and porcine hair follicles was performed 
using the novel technique confocal Raman microscopy. Based on the acquired Raman spectra, we 
could identify and differentiate between the four main components of the hair follicle (hair, epidermis, 
dermis and sebum) in both species, and conclude that their chemical compositions were nearly 
equivalent. Especially the sebum, which represents the release medium for substances taken up via the 
transfollicular pathway, showed no significant differences. Advantages of this methodology, as 
opposed to a normal staining procedure, regarding specificity and accuracy of component distribution, 
were also shown. Furthermore, confocal Raman microscopy in combination with optical profilometry 
revealed the intactness of individual hair follicles in excised cyanoacrylate skin surface biopsies on a 
three-dimensional level. This new acquired insight is of great importance because up to now the most 
common quantification method for determining follicular uptake (Differential Stripping Method) had 
only been based on the assumption that the entire follicular cast gets removed by means of 
cyanoacrylate biopsies; we were able to confirm this assumption. 
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The next section of this thesis focused on the identification and testing of potential barriers in the 
mammalian hair follicle. Consequently, expression and localization of follicular TJs, known to play a  
role in epidermal barrier properties, were looked at in the porcine ear skin model. In that sense, 
suitability of the applied porcine model was investigated again in this section and confirmed, as all 
examined TJ proteins in the porcine hair follicle were shown to be expressed and distributed similarly 
in both species by means of qPCR and immunostaining, respectively. Moreover, using an extracellular 
tracer molecule, the existence of a continuous barrier consisting of TJs was discovered throughout 
porcine hair follicles located in the outer root sheath (a continuation of the viable epidermis), and 
another TJ barrier in Huxley’s layer of the inner root sheath; in contrast, the bulb was completely 
permeable. Finally, desired modification, i.e. opening, of this TJ barrier was feasible after 
administering the TJ modulator EDTA. This could be of relevance for the drug delivery of substances 
via the transfollicular pathway in the future. The last part of this section dealt with comparing the 
distribution of the existing barriers present in the hair follicle (the stratum corneum in the upper part of 
the hair follicle, e.g. infundibulum, and the TJ barrier in the outer root sheath) with the distribution of 
an externally applied model substance – here nanoparticles – in the hair shaft, and the penetration 
behavior of these types of particles. Thus, transmission electron microscopy was employed to, for one, 
confirm for the first time that polymeric particles do stay intact upon penetration. Furthermore, it was 
demonstrated that the majority of these particles accumulated in the infundibulum of porcine hair 
follicle, the region protected by both barriers, the stratum corneum and the TJs. Few intact particles 
were also discovered past this point in the central region of the hair follicle where TJs are likely the 
only barrier.  
The last section of this work was mainly focused on the applicability of the porcine ear skin model 
with regard to follicular uptake studies. Three different polymer-based nanoparticles were prepared  
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and characterized, giving rise to three varying particle structures of differing sizes, yet equivalent 
surface charge, polydispersity, and encapsulation efficiency of drug. A desired sustained release of 
drug was achieved by means of encapsulation and this effect was similar for all three nanocarriers. 
Also, the possibility of decreasing skin permeation, and simultaneous targeting to the hair follicle, was 
shown. The reduction in skin permeation (as opposed to free drug in solution) was similar for the 
different particles and was only more reduced by increasing the viscosity of the formulation/release 
medium. The extent of follicular penetration, however, was dependent upon the molecular architecture 
of the particles, as well as on the viscosity of the formulation. For all particles, the application of a 
massage enhanced follicular uptake. The particles were all loaded with Clobetasol propionate, a very 
potent drug used for many inflammatory-based skin and hair disorders, but also known to cause severe 
adverse effects even when only applied topically. The information learned from this study could 
potentially help to minimize adverse effects by (i) releasing the drug in a time-dependent manner and 
thereby not reaching toxic concentration levels, (ii) by decreasing general skin permeability, plus (iii) 
via targeting the hair follicle as this type of therapy could revolutionize the disease management of 
several specific hair disorders (e.g. inflammatory-caused scalp diseases). Furthermore, selection of a 
specific nanocarrier and/or formulation could achieve a better delivery of the drug to the desired site of 
action, as well as a more patient-specific treatment. 
Overall, this thesis has highlighted various important aspects concerning research in the field of 
sciences ranging from characterizing and evaluating potential in vitro/ex vivo models, to performing 
basic research that deals with the anatomy of the hair follicle and its barrier properties, and lastly the 
technological approach of preparing and testing novel drug delivery systems. Combining all of the 
information learned from the discussed studies, one can say that the porcine ear skin model is indeed  
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suitable to use as a surrogate for human skin regarding (i) the testing of tight junction distribution and 
functionality in the hair follicle, and (ii) experiments concerning the uptake and penetration depth of 
nanoparticle-based drug delivery systems. This confirmation is most useful for the field of 
pharmaceutical technology, as the necessity and demand for reliable models is a topic of general 
concern. In that sense, large data sets can be generated on the model and only the most promising 
candidates (e.g. for drug delivery systems) will advance to be tested in vivo. Moreover, the 
characterization of the tight junction proteins and their barrier function in the hair follicle adds to the 
information and insight which is already known about the very complex biology of the hair follicle. 
Whether these structures are in fact a deciding factor regarding nanoparticles uptake or nanoparticle 
translocation remains to be further elucidated. Hence, more studies with a wider variety of particles 
need to be performed. Moreover, the described follicular uptake studies using the nanocarriers loaded 
with the potent glucocorticosteroid Clobetasol propionate reveal that the nanoparticle-based drug 
delivery approach is very promising not only for the recently much discussed topic of non-invasive 
transfollicular vaccination [90, 92, 145, 146], but also for the field of dermatology, especially with 
regard to inflammatory-based scalp diseases.  
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4.    Outlook 
In the future, the penetration behavior of particles ranging in size (nano-micro), molecular architecture 
(core-and-shell particles, nanospheres, liposomes, solid lipid nanoparticles), and surface charge should 
be further assessed with the goal of i) obtaining a higher follicular recovery, and ii) gaining more 
insights on what parameters are deciding regarding the location in the hair follicle that is reached. For 
these studies, transmission electron microscopy (similarly to what was done here), fluorescence 
microscopy, and/or the Differential Stripping method in vitro as well as in vivo would be of aid.  
Additionally, the ability to modulate follicular and/or epidermal TJs, which was shown to be feasible 
in this work, should be further optimized. Especially the use of more specific TJ modulators (e.g. 
Occludin mimetic peptides, Sodium caprate, Chitosan, Clostridium perfringens enterotoxin, etc.) 
should be tested to determine whether it is possible to regulate the opening and closing of this TJ 
barrier, as has been described for other epithelia before. Moreover, combining this TJ modulation with 
particle-based delivery to the hair follicle would be an intriguing approach. For example, in the field of 
non-invasive transfollicular vaccination the major challenges seen consist of delivering the antigen to 
the peri-follicular antigen presenting cells located mainly in the infundibulum of the hair follicle [145, 
146, 203]. Thus, the possibilities of i) encapsulating a specific TJ modulator along with an antigen and 
adjuvant, or ii) co-administering a specific TJ modulator along with the encapsulated antigen and 
adjuvant should be further explored.  
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5.    List of Abbreviations 
A   area of application 
AA   Alopecia areata 
ACN   acetonitrile 
ANOVA  analysis of variance 
AUC   area under the curve 
Biotin-SH  EZ-Link
TM
-Sulfo-NHS-LC-Biotin 
C   cortex 
CI   confidence interval 
CL   companion cell layer 
CCL   central cell layer 
CCT   capric/caprylic triglycerides 
Cldn   claudin 
Ct   cycle threshold 
Cu    cuticular layer of hair shaft 
CP   clobetasol propionate 
C0   average initial concentration 
D   apparent diffusion coefficient 
DLS   dynamic light scattering 
DS   Differential Stripping 
DP   dermal papilla 
DMEM   Dulbecco’s Modified Eagle Medium 
EDTA   Ethylenediaminetetraacetic acid 
EE   encapsulation efficiency 
FDA   Food and Drug Administration 
FFA   Frontal, fibrosing alopecia 
h   length of the apparent diffusion path 
He   Henle’s layer of the inner root sheath 
He* fully differentiated and highly keratinized cells in Henle’s layer of the inner 
root sheath 
H&E   haematoxylin & eosin 
H-ESI   heated-electrospray ionization 
HF   hair follicle 
HG   hydrogel 
HSE   heat-separated epidermis 
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Hu   Huxley’s layer of the inner root sheath 
icu   cuticle of the inner root sheath 
IRS   inner root sheath 
Jss   steady-state flux 
K   vehicle/barrier partition coefficient 
Kp   permeability coefficient 
LNC   lipid-core nanocapsules 
LLOQ   lower limit of quantification 
LPP   Lichen planopilaris 
M   medulla 
MC   matrix cells 
M(t)   accumulated mass of substance 
NC   nanocapsules 
NP   nanoparticle 
NS   nanospheres 
Ocln   occludin 
OECD   Organization for Economic Co-Operation and Development 
ORS   outer root sheath 
PBS   phosphate buffered saline 
PCL   poly(-ɛ-caprolactone)  
PDI   polydispersity index 
PLGA   Poly-D,L-lactide-co-glycolide 
ROI   region of interest 
SC   stratum corneum 
SCCS   Scientific Committee on Consumer Safety  
SD   standard deviation 
SEM   scanning electron microscopy 
SM   sorbitan monostearate 
SRM   selective reaction monitoring 
TER   transepithelial resistance 
TEM   transmission electron microscopy 
TJ   tight junction 
ZO-1   zonula occludens protein 1 
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